###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 2/06/2016 15:41:00 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	11.54	4.39e-24	3.98e-21	106|324|441|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00049;PF00054;PF00057;PF00059;PF00063;PF00086;PF00090;PF00093;PF00094;PF00097;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00610;PF00611;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01064;PF01302;PF01369;PF01391;PF01392;PF01403;PF01412;PF01437;PF01448;PF01485;PF01562;PF01585;PF01699;PF01753;PF01833;PF02145;PF02148;PF02177;PF02204;PF02210;PF02214;PF02218;PF02377;PF02434;PF02865;PF02931;PF03165;PF03226;PF03826;PF03920;PF04868;PF06920;PF07525;PF07645;PF07647;PF07653;PF07654;PF07679;PF08232;PF08515;PF09289;PF09324;PF09379;PF09380;PF10409;PF10608;PF12548;PF12763;PF12783;PF12796;PF12924;PF13405;PF13637;PF13639;PF13716;PF13855;PF13857;PF14324;PF14429
Group	GO:0048583	regulation of response to stimulus	1	10.47	7.59e-21	3.44e-18	109|324|503|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00049;PF00057;PF00059;PF00063;PF00086;PF00090;PF00093;PF00094;PF00097;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00373;PF00400;PF00452;PF00515;PF00564;PF00605;PF00610;PF00611;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01064;PF01217;PF01302;PF01369;PF01391;PF01392;PF01403;PF01412;PF01421;PF01437;PF01448;PF01476;PF01485;PF01562;PF01585;PF01602;PF01753;PF01833;PF02145;PF02148;PF02177;PF02204;PF02210;PF02214;PF02218;PF02377;PF02434;PF02865;PF02931;PF03165;PF03226;PF03826;PF03920;PF04868;PF06733;PF06920;PF07525;PF07534;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF08232;PF08246;PF08515;PF09289;PF09379;PF09380;PF10409;PF12548;PF12763;PF12796;PF12924;PF13405;PF13637;PF13639;PF13716;PF13855;PF13857;PF14324;PF14429
Group	GO:0032879	regulation of localization	1	10.74	2.63e-20	7.96e-18	82|324|318|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00045;PF00049;PF00059;PF00063;PF00076;PF00085;PF00086;PF00090;PF00093;PF00097;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00307;PF00349;PF00373;PF00400;PF00413;PF00435;PF00452;PF00564;PF00610;PF00611;PF00618;PF00622;PF00667;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00884;PF00928;PF00969;PF01030;PF01044;PF01064;PF01217;PF01302;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02185;PF02204;PF02210;PF02214;PF02931;PF04810;PF07546;PF07645;PF07647;PF07651;PF07653;PF07654;PF07679;PF07686;PF07690;PF08246;PF10409;PF12548;PF12697;PF12796;PF13405;PF13426;PF13637;PF13716;PF13855;PF13903
Group	GO:0010646	regulation of cell communication	1	10.15	1.18e-18	2.67e-16	82|324|336|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00049;PF00057;PF00059;PF00063;PF00086;PF00093;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01064;PF01302;PF01391;PF01392;PF01403;PF01437;PF01448;PF01485;PF01585;PF01699;PF01833;PF02145;PF02210;PF02214;PF02218;PF02434;PF02865;PF02931;PF03165;PF03226;PF03826;PF03920;PF04868;PF07525;PF07645;PF07653;PF07654;PF07679;PF08515;PF09289;PF09379;PF09380;PF10409;PF10608;PF12548;PF12763;PF12796;PF13405;PF13637;PF13639;PF13716;PF13855;PF13857;PF14324
Group	GO:0007399	nervous system development	1	9.87	2.98e-18	5.41e-16	90|324|397|3527	PF00019;PF00024;PF00041;PF00049;PF00052;PF00053;PF00054;PF00057;PF00063;PF00090;PF00122;PF00130;PF00168;PF00169;PF00254;PF00307;PF00373;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00564;PF00610;PF00611;PF00618;PF00651;PF00688;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF01030;PF01044;PF01064;PF01369;PF01391;PF01392;PF01400;PF01403;PF01421;PF01437;PF01562;PF01833;PF02023;PF02145;PF02148;PF02177;PF02181;PF02210;PF02263;PF02377;PF02865;PF02931;PF03165;PF03826;PF03953;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07647;PF07653;PF07679;PF07686;PF08506;PF08515;PF08736;PF08788;PF09379;PF09380;PF10409;PF10524;PF10600;PF10608;PF12548;PF12796;PF12924;PF13385;PF13716;PF13855;PF13857;PF13903;PF14324
Group	GO:0048519	negative regulation of biological process	1	9.37	4.50e-18	6.80e-16	126|324|681|3527	PF00019;PF00024;PF00041;PF00049;PF00057;PF00076;PF00086;PF00090;PF00093;PF00097;PF00106;PF00122;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00241;PF00254;PF00258;PF00270;PF00271;PF00307;PF00349;PF00350;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00611;PF00622;PF00642;PF00651;PF00667;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00789;PF00884;PF00969;PF01030;PF01064;PF01088;PF01302;PF01335;PF01391;PF01392;PF01400;PF01403;PF01426;PF01448;PF01477;PF01562;PF01585;PF01602;PF01699;PF01753;PF01833;PF01909;PF02145;PF02148;PF02177;PF02181;PF02210;PF02214;PF02865;PF02931;PF03165;PF03226;PF03920;PF05033;PF05773;PF06733;PF06741;PF07525;PF07546;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF08210;PF08246;PF08515;PF09058;PF09289;PF09379;PF09380;PF10409;PF10524;PF10600;PF10608;PF11934;PF12047;PF12548;PF12697;PF12763;PF12796;PF12906;PF12924;PF12947;PF13086;PF13405;PF13415;PF13638;PF13639;PF13716;PF13733;PF13854;PF13855;PF13857;PF14259;PF14324
Group	GO:0051239	regulation of multicellular organismal process	1	9.60	9.92e-18	1.12e-15	96|324|448|3527	PF00019;PF00020;PF00024;PF00027;PF00041;PF00049;PF00054;PF00059;PF00063;PF00076;PF00086;PF00090;PF00093;PF00122;PF00130;PF00168;PF00169;PF00240;PF00254;PF00258;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00642;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00884;PF00969;PF01064;PF01391;PF01392;PF01403;PF01437;PF01562;PF01699;PF01753;PF01833;PF02023;PF02177;PF02181;PF02198;PF02210;PF02214;PF02377;PF02518;PF02865;PF02931;PF03165;PF03226;PF04818;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF08246;PF08515;PF10409;PF10524;PF10608;PF11933;PF12045;PF12548;PF12763;PF12796;PF12924;PF12947;PF13405;PF13426;PF13716;PF13855;PF13857
Group	GO:0065008	regulation of biological quality	1	9.34	8.97e-18	1.12e-15	119|324|628|3527	PF00019;PF00024;PF00027;PF00041;PF00049;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00094;PF00106;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00240;PF00241;PF00254;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00530;PF00583;PF00610;PF00611;PF00618;PF00622;PF00642;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00780;PF00928;PF01044;PF01064;PF01217;PF01302;PF01336;PF01391;PF01392;PF01403;PF01421;PF01433;PF01437;PF01477;PF01496;PF01553;PF01562;PF01602;PF01699;PF01826;PF01841;PF02023;PF02145;PF02148;PF02177;PF02181;PF02210;PF02214;PF02218;PF02225;PF02828;PF02865;PF02931;PF03165;PF04389;PF06367;PF06371;PF06733;PF06741;PF06920;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07690;PF07707;PF07973;PF08246;PF08515;PF08736;PF08742;PF09379;PF09380;PF10409;PF10600;PF10608;PF11933;PF11971;PF12710;PF12756;PF12763;PF12796;PF12924;PF13246;PF13405;PF13637;PF13716;PF13855;PF13857;PF13903;PF14259;PF14429
Group	GO:0019538	protein metabolic process	1	8.82	6.98e-17	7.03e-15	145|324|869|3527	PF00019;PF00027;PF00040;PF00041;PF00045;PF00049;PF00054;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00090;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00385;PF00400;PF00413;PF00415;PF00432;PF00452;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00651;PF00667;PF00675;PF00687;PF00688;PF00702;PF00754;PF00757;PF00780;PF00789;PF00884;PF00899;PF00989;PF01030;PF01064;PF01088;PF01302;PF01336;PF01391;PF01400;PF01421;PF01426;PF01433;PF01448;PF01471;PF01485;PF01546;PF01562;PF01663;PF01753;PF01841;PF02008;PF02148;PF02177;PF02185;PF02210;PF02214;PF02225;PF02434;PF02518;PF02824;PF02865;PF03062;PF03133;PF03147;PF03165;PF03256;PF03953;PF04137;PF04389;PF04810;PF04818;PF04868;PF05020;PF05021;PF05033;PF05193;PF05773;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07687;PF07707;PF07973;PF08246;PF08515;PF08662;PF08736;PF08926;PF09379;PF09380;PF09409;PF10409;PF11717;PF12548;PF12697;PF12796;PF12894;PF12895;PF12906;PF12924;PF13344;PF13405;PF13415;PF13426;PF13519;PF13589;PF13637;PF13639;PF13733;PF13831;PF13832;PF13848;PF13855;PF13857;PF14324
Group	GO:0050793	regulation of developmental process	1	9.10	5.10e-16	4.63e-14	87|324|405|3527	PF00019;PF00024;PF00041;PF00049;PF00057;PF00063;PF00076;PF00086;PF00090;PF00093;PF00130;PF00168;PF00169;PF00179;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00642;PF00651;PF00688;PF00778;PF00780;PF00884;PF01064;PF01391;PF01392;PF01403;PF01437;PF01562;PF01753;PF01833;PF02177;PF02181;PF02185;PF02198;PF02210;PF02377;PF02518;PF02865;PF02931;PF03165;PF03226;PF03826;PF04818;PF06367;PF06371;PF07525;PF07531;PF07645;PF07647;PF07654;PF07679;PF07686;PF08246;PF08515;PF08736;PF09379;PF09380;PF10409;PF10524;PF12045;PF12548;PF12763;PF12796;PF12906;PF12924;PF12947;PF13405;PF13637;PF13716;PF13855;PF14259
Group	GO:0043412	macromolecule modification	1	8.47	5.29e-15	4.36e-13	110|324|602|3527	PF00019;PF00027;PF00041;PF00049;PF00054;PF00063;PF00076;PF00085;PF00094;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00383;PF00385;PF00400;PF00415;PF00432;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00651;PF00667;PF00688;PF00754;PF00757;PF00780;PF00899;PF00989;PF01030;PF01064;PF01088;PF01189;PF01302;PF01426;PF01448;PF01485;PF01585;PF01663;PF01753;PF01841;PF02008;PF02148;PF02177;PF02185;PF02210;PF02214;PF02225;PF02434;PF02518;PF02865;PF03062;PF03133;PF03165;PF03256;PF04389;PF04408;PF04762;PF04810;PF04818;PF04868;PF05033;PF05773;PF06464;PF07645;PF07647;PF07653;PF07679;PF07707;PF08210;PF08515;PF08736;PF08926;PF09379;PF09380;PF10409;PF11717;PF12047;PF12697;PF12796;PF12894;PF12895;PF12906;PF12924;PF13344;PF13415;PF13426;PF13637;PF13639;PF13733;PF13831;PF13832;PF13855;PF13857;PF14324
Group	GO:0031323	regulation of cellular metabolic process	1	8.17	8.10e-15	6.12e-13	140|324|867|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00054;PF00057;PF00059;PF00063;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00642;PF00651;PF00688;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01064;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01448;PF01477;PF01585;PF01751;PF01753;PF01833;PF02008;PF02023;PF02145;PF02148;PF02177;PF02198;PF02204;PF02210;PF02218;PF02377;PF02518;PF02770;PF02771;PF02865;PF02931;PF02985;PF03165;PF03826;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06733;PF06920;PF07258;PF07500;PF07525;PF07528;PF07531;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07973;PF08210;PF08313;PF08447;PF08515;PF08662;PF08711;PF08788;PF09379;PF09380;PF10524;PF10600;PF10608;PF11717;PF11934;PF11971;PF12045;PF12047;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13415;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF14259;PF14324;PF14429
Group	GO:0048518	positive regulation of biological process	1	8.30	1.13e-14	7.87e-13	117|324|667|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00041;PF00049;PF00053;PF00054;PF00057;PF00059;PF00063;PF00076;PF00086;PF00090;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00179;PF00240;PF00241;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00611;PF00618;PF00642;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF00989;PF01030;PF01064;PF01302;PF01335;PF01391;PF01392;PF01403;PF01426;PF01437;PF01448;PF01476;PF01485;PF01562;PF01585;PF01699;PF01833;PF02177;PF02181;PF02185;PF02198;PF02204;PF02210;PF02218;PF02434;PF02518;PF02865;PF02931;PF03165;PF03826;PF04868;PF05790;PF06367;PF06371;PF06733;PF07525;PF07534;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF08210;PF08246;PF08313;PF08447;PF08515;PF08788;PF10409;PF10524;PF11717;PF11971;PF12045;PF12548;PF12697;PF12756;PF12763;PF12796;PF12924;PF13086;PF13405;PF13637;PF13639;PF13716;PF13855;PF14259;PF14324
Group	GO:0006928	cellular component movement	1	8.79	1.64e-14	1.07e-12	69|324|296|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00063;PF00130;PF00168;PF00169;PF00226;PF00241;PF00307;PF00373;PF00400;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF00928;PF00989;PF01030;PF01064;PF01217;PF01302;PF01403;PF01437;PF01471;PF01562;PF01602;PF01833;PF02148;PF02177;PF02181;PF02185;PF02210;PF02214;PF03133;PF03826;PF06367;PF06371;PF06920;PF07645;PF07647;PF07653;PF07679;PF07686;PF07728;PF08393;PF08447;PF08515;PF09379;PF10409;PF11971;PF12774;PF12775;PF12780;PF12924;PF13405;PF13855;PF14429
Group	GO:0051641	cellular localization	1	8.33	3.16e-14	1.91e-12	95|324|494|3527	PF00019;PF00027;PF00041;PF00053;PF00054;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00400;PF00432;PF00435;PF00452;PF00515;PF00610;PF00611;PF00618;PF00622;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00928;PF00989;PF01044;PF01217;PF01302;PF01369;PF01391;PF01392;PF01403;PF01412;PF01465;PF01602;PF02064;PF02138;PF02145;PF02177;PF02181;PF02210;PF02828;PF02865;PF02931;PF02985;PF03810;PF03953;PF04695;PF04810;PF05193;PF06046;PF07645;PF07651;PF07653;PF07679;PF07707;PF07728;PF08389;PF08393;PF08447;PF08506;PF09324;PF10600;PF10608;PF11971;PF12756;PF12763;PF12774;PF12775;PF12780;PF12783;PF12796;PF12924;PF13246;PF13385;PF13405;PF13513;PF13637;PF13850;PF13855
Group	GO:0032990	cell part morphogenesis	1	8.80	7.03e-14	3.99e-12	55|324|210|3527	PF00024;PF00041;PF00052;PF00053;PF00054;PF00063;PF00090;PF00130;PF00168;PF00169;PF00271;PF00307;PF00400;PF00415;PF00435;PF00515;PF00611;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01064;PF01391;PF01400;PF01403;PF01437;PF01833;PF02148;PF02177;PF02210;PF02263;PF02377;PF03133;PF03165;PF03953;PF06741;PF07645;PF07647;PF07653;PF07679;PF08515;PF08736;PF10162;PF10524;PF10600;PF10608;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0080090	regulation of primary metabolic process	1	7.72	1.86e-13	8.90e-12	136|324|861|3527	PF00019;PF00020;PF00024;PF00027;PF00041;PF00049;PF00054;PF00057;PF00059;PF00063;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01064;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01448;PF01585;PF01751;PF01753;PF01833;PF02008;PF02023;PF02145;PF02148;PF02177;PF02198;PF02204;PF02210;PF02218;PF02377;PF02865;PF02931;PF02985;PF03165;PF03826;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06733;PF06920;PF07258;PF07500;PF07525;PF07528;PF07531;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07973;PF08210;PF08313;PF08447;PF08515;PF08662;PF08711;PF08788;PF09379;PF09380;PF10524;PF11717;PF11934;PF11971;PF12045;PF12047;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13415;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF14259;PF14324;PF14429
Group	GO:0051128	regulation of cellular component organization	1	8.25	2.50e-13	1.13e-11	72|324|333|3527	PF00019;PF00024;PF00041;PF00049;PF00059;PF00063;PF00086;PF00130;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00452;PF00515;PF00610;PF00611;PF00618;PF00622;PF00651;PF00688;PF00754;PF00757;PF00780;PF01030;PF01044;PF01064;PF01088;PF01302;PF01391;PF01392;PF01403;PF01437;PF01562;PF01833;PF02008;PF02145;PF02148;PF02181;PF02185;PF02210;PF02518;PF02931;PF03165;PF06367;PF06371;PF06733;PF07645;PF07647;PF07651;PF07653;PF07679;PF07686;PF07707;PF08210;PF08515;PF08736;PF09379;PF09380;PF10409;PF12796;PF12895;PF12906;PF13637;PF13855
Group	GO:0051234	establishment of localization	1	7.69	3.29e-13	1.36e-11	127|324|785|3527	PF00019;PF00027;PF00040;PF00041;PF00049;PF00053;PF00057;PF00059;PF00063;PF00076;PF00085;PF00106;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00349;PF00350;PF00400;PF00432;PF00435;PF00452;PF00501;PF00515;PF00610;PF00611;PF00618;PF00622;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00928;PF00989;PF01033;PF01064;PF01145;PF01217;PF01302;PF01369;PF01391;PF01412;PF01426;PF01448;PF01465;PF01477;PF01496;PF01553;PF01554;PF01562;PF01602;PF01699;PF01833;PF02064;PF02138;PF02145;PF02177;PF02210;PF02214;PF02225;PF02770;PF02828;PF02865;PF02931;PF02985;PF03765;PF03810;PF03953;PF04389;PF04695;PF04810;PF05193;PF06046;PF07258;PF07546;PF07645;PF07647;PF07651;PF07653;PF07679;PF07686;PF07690;PF07707;PF07728;PF08246;PF08389;PF08393;PF08447;PF08506;PF08515;PF09324;PF11933;PF11971;PF12710;PF12763;PF12774;PF12775;PF12780;PF12783;PF12796;PF12924;PF12947;PF13246;PF13385;PF13405;PF13415;PF13418;PF13426;PF13513;PF13519;PF13637;PF13850;PF13855;PF14259
Group	GO:0033036	macromolecule localization	1	8.05	6.81e-13	2.68e-11	74|324|354|3527	PF00019;PF00041;PF00052;PF00053;PF00054;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00169;PF00226;PF00240;PF00241;PF00270;PF00271;PF00307;PF00350;PF00373;PF00400;PF00432;PF00435;PF00501;PF00515;PF00564;PF00611;PF00675;PF00683;PF00688;PF00778;PF00928;PF01044;PF01064;PF01217;PF01302;PF01391;PF01392;PF01465;PF01477;PF01602;PF02064;PF02145;PF02210;PF02828;PF02865;PF02985;PF03765;PF03810;PF04695;PF04810;PF05193;PF07645;PF07653;PF07679;PF08389;PF08506;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF12710;PF12763;PF12796;PF13246;PF13405;PF13415;PF13418;PF13513;PF13637;PF13855;PF14259
Group	GO:0040011	locomotion	1	7.99	1.05e-12	3.80e-11	72|324|342|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00063;PF00090;PF00130;PF00169;PF00226;PF00241;PF00307;PF00373;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01064;PF01391;PF01392;PF01400;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02148;PF02177;PF02185;PF02210;PF02214;PF02518;PF02931;PF03165;PF03826;PF03953;PF06367;PF06371;PF06920;PF07645;PF07647;PF07653;PF07679;PF07686;PF07728;PF08393;PF08447;PF08515;PF08736;PF10409;PF10524;PF11971;PF12774;PF12775;PF12780;PF12924;PF13426;PF13855;PF14429
Group	GO:0007163	establishment or maintenance of cell polarity	1	8.94	1.33e-12	4.48e-11	32|324|88|3527	PF00041;PF00052;PF00053;PF00054;PF00057;PF00063;PF00130;PF00169;PF00307;PF00373;PF00400;PF00435;PF00564;PF00610;PF00651;PF00778;PF01302;PF01369;PF02181;PF02210;PF02828;PF06367;PF06371;PF07653;PF07679;PF08736;PF09379;PF09380;PF10600;PF10608;PF13855;PF14259
Group	GO:0065009	regulation of molecular function	1	7.87	1.29e-12	4.48e-11	79|324|396|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00057;PF00063;PF00076;PF00085;PF00086;PF00090;PF00097;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00307;PF00373;PF00400;PF00415;PF00452;PF00564;PF00610;PF00611;PF00618;PF00622;PF00667;PF00688;PF00757;PF00778;PF00780;PF00899;PF01302;PF01335;PF01391;PF01392;PF01403;PF01412;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02204;PF02210;PF02377;PF02434;PF02865;PF02931;PF03165;PF04868;PF06920;PF07258;PF07525;PF07645;PF07647;PF07653;PF07679;PF08246;PF08736;PF09324;PF09379;PF09380;PF10600;PF10608;PF11934;PF11971;PF12796;PF12924;PF13405;PF13716;PF13855;PF13903;PF14429
Group	GO:0009605	response to external stimulus	1	7.94	1.60e-12	5.17e-11	70|324|330|3527	PF00019;PF00020;PF00027;PF00041;PF00052;PF00053;PF00054;PF00059;PF00063;PF00076;PF00082;PF00090;PF00122;PF00149;PF00271;PF00307;PF00373;PF00400;PF00435;PF00501;PF00564;PF00618;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00778;PF00780;PF00899;PF00969;PF01064;PF01179;PF01391;PF01392;PF01400;PF01403;PF01437;PF01833;PF02145;PF02148;PF02177;PF02210;PF02518;PF02824;PF02865;PF02931;PF03165;PF03953;PF05773;PF06920;PF07645;PF07647;PF07654;PF07679;PF07686;PF08246;PF08515;PF08736;PF10409;PF10524;PF12796;PF12924;PF13426;PF13637;PF13855;PF13857;PF14429
Group	GO:0030030	cell projection organization	1	8.10	1.87e-12	5.65e-11	58|324|246|3527	PF00019;PF00024;PF00041;PF00052;PF00053;PF00054;PF00063;PF00090;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00610;PF00611;PF00618;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01064;PF01391;PF01400;PF01403;PF01437;PF01833;PF02148;PF02177;PF02210;PF02263;PF02377;PF03133;PF03165;PF03953;PF06741;PF07645;PF07647;PF07653;PF07679;PF08515;PF08736;PF10162;PF10524;PF10600;PF10608;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0051674	localization of cell	1	8.03	3.48e-12	9.85e-11	55|324|229|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00063;PF00130;PF00226;PF00241;PF00307;PF00373;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02210;PF02214;PF03826;PF06367;PF06371;PF06920;PF07645;PF07647;PF07653;PF07679;PF07686;PF07728;PF08393;PF08447;PF08515;PF10409;PF11971;PF12774;PF12775;PF12780;PF13855;PF14429
Group	GO:0060255	regulation of macromolecule metabolic process	1	7.07	1.23e-11	3.19e-10	132|324|868|3527	PF00019;PF00020;PF00024;PF00027;PF00041;PF00049;PF00054;PF00057;PF00059;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00515;PF00530;PF00564;PF00605;PF00610;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01064;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01400;PF01403;PF01426;PF01437;PF01448;PF01477;PF01585;PF01751;PF01753;PF01833;PF02008;PF02023;PF02145;PF02148;PF02177;PF02198;PF02204;PF02210;PF02218;PF02377;PF02865;PF02931;PF02985;PF03165;PF03826;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06464;PF06733;PF07258;PF07500;PF07525;PF07528;PF07531;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07973;PF08210;PF08246;PF08313;PF08447;PF08515;PF08662;PF08711;PF08788;PF09379;PF09380;PF10409;PF10524;PF11717;PF11934;PF12045;PF12047;PF12756;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13415;PF13638;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF14259;PF14324
Group	GO:0000902	cell morphogenesis	1	7.66	1.58e-11	3.99e-10	59|324|265|3527	PF00019;PF00024;PF00041;PF00052;PF00053;PF00054;PF00063;PF00090;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00530;PF00611;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01064;PF01391;PF01392;PF01400;PF01403;PF01437;PF01833;PF02148;PF02177;PF02210;PF02263;PF02377;PF03133;PF03165;PF03953;PF06741;PF06920;PF07645;PF07647;PF07653;PF07679;PF08515;PF08736;PF10162;PF10524;PF10600;PF10608;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0007154	cell communication	1	7.13	1.80e-11	4.40e-10	112|324|691|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00090;PF00106;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00899;PF00928;PF00969;PF00989;PF01030;PF01044;PF01064;PF01179;PF01217;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01421;PF01437;PF01465;PF01562;PF01602;PF01833;PF02023;PF02140;PF02145;PF02177;PF02185;PF02210;PF02214;PF02377;PF02518;PF02759;PF02824;PF02828;PF02865;PF02931;PF03165;PF03920;PF05773;PF05790;PF07525;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07690;PF07707;PF08246;PF08447;PF08506;PF08515;PF10409;PF10600;PF10608;PF11933;PF11971;PF12548;PF12763;PF12796;PF12874;PF12924;PF13426;PF13639;PF13716;PF13855;PF13857
Group	GO:0042221	response to chemical stimulus	1	7.14	2.28e-11	5.44e-10	103|324|615|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00045;PF00049;PF00052;PF00053;PF00054;PF00057;PF00059;PF00063;PF00076;PF00085;PF00090;PF00093;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00583;PF00605;PF00622;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00969;PF00989;PF01030;PF01064;PF01179;PF01370;PF01391;PF01392;PF01400;PF01403;PF01437;PF01471;PF01554;PF01833;PF01909;PF02145;PF02148;PF02177;PF02210;PF02218;PF02263;PF02518;PF02865;PF02931;PF03165;PF03953;PF06920;PF07525;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07690;PF08246;PF08416;PF08447;PF08515;PF08736;PF10409;PF10524;PF11933;PF12796;PF12924;PF13405;PF13426;PF13639;PF13716;PF13848;PF13855;PF14429
Group	GO:0009790	embryo development	1	7.44	3.70e-11	8.62e-10	63|324|299|3527	PF00019;PF00041;PF00052;PF00053;PF00054;PF00057;PF00063;PF00076;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00307;PF00373;PF00400;PF00435;PF00452;PF00564;PF00583;PF00610;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00884;PF00989;PF01030;PF01064;PF01391;PF01392;PF01403;PF01448;PF02008;PF02145;PF02185;PF02210;PF02377;PF02828;PF03165;PF03826;PF03953;PF05033;PF07525;PF07645;PF07647;PF07653;PF07679;PF07686;PF08447;PF08515;PF08736;PF09379;PF09380;PF12045;PF12548;PF12796;PF13857
Group	GO:0023052	signaling	1	6.99	4.72e-11	1.04e-09	106|324|648|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00057;PF00059;PF00063;PF00076;PF00085;PF00090;PF00106;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00610;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00928;PF00969;PF00989;PF01030;PF01044;PF01064;PF01217;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01421;PF01437;PF01465;PF01562;PF01602;PF01833;PF02023;PF02140;PF02145;PF02177;PF02185;PF02210;PF02214;PF02377;PF02518;PF02759;PF02828;PF02865;PF02931;PF03165;PF05790;PF07525;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07690;PF07707;PF08246;PF08447;PF08506;PF08515;PF10409;PF10600;PF10608;PF11933;PF11971;PF12548;PF12763;PF12796;PF12874;PF12924;PF13426;PF13639;PF13716;PF13855;PF13857
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	6.56	5.65e-10	1.05e-08	103|324|647|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00063;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00270;PF00271;PF00307;PF00385;PF00400;PF00435;PF00515;PF00530;PF00564;PF00605;PF00610;PF00611;PF00618;PF00642;PF00651;PF00688;PF00757;PF00780;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01448;PF01585;PF01751;PF01753;PF01833;PF02008;PF02023;PF02145;PF02177;PF02198;PF02204;PF02518;PF02865;PF03165;PF03826;PF03920;PF04408;PF04762;PF04818;PF05033;PF06733;PF06920;PF07258;PF07500;PF07528;PF07531;PF07645;PF07647;PF07653;PF07679;PF08210;PF08313;PF08447;PF08515;PF08711;PF08788;PF10524;PF11717;PF11934;PF11971;PF12045;PF12047;PF12756;PF12796;PF12895;PF12924;PF13086;PF13405;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF14259;PF14324;PF14429
Group	GO:0006950	response to stress	1	6.38	1.24e-09	2.12e-08	109|324|709|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00041;PF00045;PF00049;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00094;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00530;PF00534;PF00564;PF00605;PF00618;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00780;PF00817;PF00899;PF00969;PF00989;PF01030;PF01033;PF01179;PF01302;PF01336;PF01391;PF01471;PF01476;PF01477;PF01826;PF01833;PF01841;PF01909;PF02145;PF02177;PF02210;PF02263;PF02518;PF02824;PF02865;PF02931;PF03953;PF04005;PF04389;PF05773;PF05790;PF06733;PF06920;PF07534;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF08246;PF08447;PF08515;PF08742;PF10391;PF10409;PF11717;PF11799;PF12697;PF12842;PF12924;PF12947;PF13086;PF13405;PF13589;PF13639;PF13716;PF13848;PF13855;PF14324;PF14429
Group	GO:0000003	reproduction	1	6.20	1.01e-08	1.43e-07	72|324|412|3527	PF00019;PF00041;PF00045;PF00049;PF00053;PF00063;PF00076;PF00106;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00400;PF00413;PF00435;PF00452;PF00564;PF00618;PF00622;PF00651;PF00667;PF00688;PF00702;PF00754;PF00757;PF00780;PF00989;PF01030;PF01064;PF01335;PF01392;PF01421;PF01465;PF01471;PF01553;PF01562;PF01751;PF01753;PF02177;PF02181;PF02518;PF02865;PF02931;PF03062;PF03165;PF03953;PF04408;PF05033;PF07525;PF07647;PF07653;PF07679;PF07686;PF08515;PF09335;PF12478;PF12796;PF12924;PF13589;PF13855;PF13857;PF14259
Group	GO:0051716	cellular response to stimulus	1	5.12	5.58e-07	5.82e-06	116|324|853|3527	PF00019;PF00020;PF00027;PF00040;PF00041;PF00049;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00090;PF00093;PF00106;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00452;PF00501;PF00564;PF00583;PF00605;PF00610;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00817;PF00884;PF00899;PF00969;PF00989;PF01030;PF01064;PF01179;PF01302;PF01336;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01562;PF01833;PF01909;PF02140;PF02145;PF02177;PF02185;PF02263;PF02377;PF02518;PF02759;PF02824;PF02865;PF02931;PF03165;PF04005;PF05773;PF05790;PF06733;PF07525;PF07645;PF07647;PF07653;PF07654;PF07679;PF07686;PF07707;PF08246;PF08447;PF08506;PF08515;PF10391;PF10409;PF11717;PF11799;PF11971;PF12548;PF12763;PF12796;PF12842;PF12874;PF12924;PF13086;PF13405;PF13426;PF13589;PF13639;PF13716;PF13848;PF13855;PF13857;PF14324
Group	GO:0002376	immune system process	1	5.04	2.57e-06	2.20e-05	56|324|334|3527	PF00019;PF00020;PF00041;PF00057;PF00059;PF00063;PF00085;PF00090;PF00130;PF00153;PF00168;PF00169;PF00179;PF00240;PF00254;PF00270;PF00271;PF00350;PF00452;PF00605;PF00651;PF00688;PF00780;PF00969;PF01033;PF01335;PF01391;PF01392;PF01433;PF01476;PF01562;PF01909;PF02138;PF02218;PF02263;PF02865;PF02931;PF04810;PF05790;PF07534;PF07645;PF07653;PF07654;PF07679;PF07686;PF08246;PF08515;PF10409;PF11971;PF12697;PF12796;PF13637;PF13639;PF13855;PF13857;PF14324
Group	GO:0044260	cellular macromolecule metabolic process	1	4.53	4.78e-06	3.98e-05	169|324|1425|3527	PF00019;PF00027;PF00041;PF00049;PF00054;PF00057;PF00063;PF00076;PF00082;PF00085;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00383;PF00385;PF00400;PF00415;PF00432;PF00452;PF00515;PF00530;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00642;PF00651;PF00667;PF00675;PF00687;PF00688;PF00702;PF00754;PF00757;PF00780;PF00789;PF00817;PF00884;PF00899;PF00989;PF01030;PF01064;PF01088;PF01189;PF01302;PF01336;PF01370;PF01426;PF01448;PF01480;PF01485;PF01562;PF01585;PF01663;PF01751;PF01753;PF01805;PF01841;PF01909;PF02008;PF02023;PF02148;PF02177;PF02185;PF02198;PF02210;PF02214;PF02225;PF02269;PF02434;PF02518;PF02824;PF02865;PF03062;PF03133;PF03147;PF03165;PF03256;PF03826;PF03953;PF04137;PF04389;PF04408;PF04561;PF04563;PF04762;PF04810;PF04818;PF04868;PF05020;PF05021;PF05033;PF05193;PF05485;PF05773;PF06464;PF06733;PF07034;PF07500;PF07528;PF07531;PF07645;PF07647;PF07653;PF07679;PF07707;PF07973;PF08075;PF08210;PF08447;PF08515;PF08662;PF08711;PF08736;PF08926;PF09379;PF09380;PF09409;PF10391;PF10409;PF10524;PF11717;PF11799;PF12047;PF12548;PF12697;PF12796;PF12842;PF12874;PF12894;PF12895;PF12906;PF12924;PF13086;PF13344;PF13415;PF13426;PF13519;PF13589;PF13637;PF13638;PF13639;PF13656;PF13691;PF13733;PF13831;PF13832;PF13848;PF13855;PF13857;PF14259;PF14324
Group	GO:0009889	regulation of biosynthetic process	1	4.47	1.32e-05	9.52e-05	89|324|646|3527	PF00019;PF00020;PF00049;PF00059;PF00076;PF00097;PF00130;PF00168;PF00169;PF00179;PF00270;PF00271;PF00307;PF00349;PF00385;PF00400;PF00435;PF00515;PF00530;PF00564;PF00605;PF00642;PF00651;PF00688;PF00757;PF00899;PF00989;PF01030;PF01064;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01426;PF01448;PF01585;PF01753;PF01833;PF02008;PF02023;PF02177;PF02198;PF02518;PF02865;PF03165;PF03826;PF03920;PF04762;PF04818;PF05033;PF05773;PF07258;PF07500;PF07528;PF07531;PF07645;PF07654;PF07679;PF07686;PF07973;PF08210;PF08313;PF08447;PF08515;PF08662;PF08711;PF08788;PF10524;PF11717;PF11934;PF12045;PF12047;PF12756;PF12796;PF12895;PF12924;PF13086;PF13405;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF14259;PF14324
Group	GO:0009056	catabolic process	1	3.90	1.33e-04	6.63e-04	74|324|543|3527	PF00019;PF00049;PF00063;PF00082;PF00085;PF00097;PF00122;PF00149;PF00153;PF00168;PF00179;PF00205;PF00226;PF00240;PF00258;PF00270;PF00271;PF00289;PF00349;PF00350;PF00383;PF00400;PF00452;PF00456;PF00501;PF00515;PF00557;PF00564;PF00583;PF00622;PF00642;PF00667;PF00688;PF00689;PF00690;PF00702;PF00789;PF00899;PF00970;PF01370;PF01391;PF01433;PF01477;PF01485;PF01546;PF01597;PF01841;PF01909;PF02148;PF02214;PF02263;PF02518;PF02770;PF02771;PF03256;PF03953;PF04389;PF05020;PF05021;PF07707;PF07728;PF08210;PF08246;PF09409;PF10409;PF12697;PF12842;PF12895;PF13086;PF13519;PF13589;PF13638;PF13639;PF14259
Group	GO:0030198	extracellular matrix organization	2	9.78	9.84e-14	5.25e-12	28|324|63|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00063;PF00086;PF00090;PF00093;PF00413;PF00530;PF00688;PF01391;PF01392;PF01421;PF01471;PF01562;PF02177;PF02210;PF04810;PF07679;PF08515;PF12924;PF13716;PF13733;PF13855
Group	GO:0001932	regulation of protein phosphorylation	2	8.86	1.23e-13	6.21e-12	48|324|169|3527	PF00019;PF00020;PF00027;PF00041;PF00049;PF00057;PF00097;PF00169;PF00226;PF00240;PF00373;PF00400;PF00415;PF00452;PF00564;PF00610;PF00688;PF00757;PF00778;PF00780;PF01030;PF01064;PF01302;PF01391;PF01392;PF01403;PF01437;PF01585;PF02145;PF02177;PF02210;PF02218;PF02377;PF02931;PF04868;PF07525;PF07645;PF07653;PF07679;PF08515;PF09379;PF09380;PF11934;PF12796;PF12924;PF13405;PF13716;PF13855
Group	GO:0007444	imaginal disc development	2	9.35	2.76e-13	1.19e-11	31|324|79|3527	PF00041;PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07653;PF07679;PF07686;PF08515;PF09379;PF12796;PF13637;PF13855;PF14259;PF14324
Group	GO:0060541	respiratory system development	2	9.08	9.08e-13	3.43e-11	31|324|82|3527	PF00019;PF00041;PF00045;PF00049;PF00057;PF00059;PF00130;PF00240;PF00307;PF00413;PF00435;PF00564;PF00688;PF01064;PF01391;PF01471;PF02181;PF02828;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF08447;PF08515;PF10409;PF10524;PF13855;PF13903
Group	GO:0007552	metamorphosis	2	9.03	1.77e-12	5.52e-11	29|324|74|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08515;PF08736;PF09379;PF10409;PF12796;PF13855;PF14259
Group	GO:0042060	wound healing	2	8.81	2.80e-12	8.18e-11	31|324|85|3527	PF00024;PF00027;PF00041;PF00063;PF00093;PF00094;PF00122;PF00130;PF00168;PF00169;PF00307;PF00373;PF00435;PF00618;PF00622;PF00689;PF00690;PF00702;PF00754;PF00757;PF01030;PF01826;PF01841;PF04389;PF06920;PF07653;PF07679;PF07686;PF08742;PF13716;PF14429
Group	GO:0002165	instar larval or pupal development	2	8.78	4.05e-12	1.11e-10	30|324|81|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08515;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF14259
Group	GO:0009886	post-embryonic morphogenesis	2	8.56	8.11e-12	2.16e-10	31|324|88|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08515;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF14259
Group	GO:0031329	regulation of cellular catabolic process	2	8.02	4.12e-11	9.33e-10	35|324|115|3527	PF00027;PF00041;PF00063;PF00076;PF00130;PF00168;PF00169;PF00226;PF00240;PF00271;PF00307;PF00373;PF00400;PF00515;PF00610;PF00611;PF00618;PF00642;PF00778;PF00780;PF00789;PF01403;PF01412;PF01437;PF02145;PF02148;PF02204;PF06920;PF07647;PF07653;PF11971;PF12697;PF13716;PF13855;PF14429
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	8.28	7.56e-11	1.60e-09	26|324|69|3527	PF00041;PF00063;PF00130;PF00168;PF00169;PF00610;PF00611;PF00618;PF00651;PF00780;PF01369;PF01403;PF01412;PF01437;PF01833;PF02145;PF02204;PF02214;PF06920;PF07647;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0016477	cell migration	2	7.58	7.40e-11	1.60e-09	46|324|185|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00063;PF00130;PF00307;PF00413;PF00435;PF00515;PF00530;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02210;PF02214;PF03826;PF06367;PF06371;PF06920;PF07645;PF07647;PF07653;PF07679;PF07686;PF08447;PF08515;PF10409;PF11971;PF13855;PF14429
Group	GO:0006508	proteolysis	2	7.58	8.20e-11	1.69e-09	45|324|179|3527	PF00040;PF00045;PF00057;PF00063;PF00076;PF00082;PF00085;PF00090;PF00097;PF00168;PF00179;PF00226;PF00240;PF00400;PF00413;PF00452;PF00515;PF00530;PF00622;PF00675;PF00789;PF01400;PF01421;PF01433;PF01471;PF01485;PF01546;PF01562;PF02148;PF02214;PF02225;PF03256;PF03953;PF04389;PF05020;PF05021;PF05193;PF07687;PF07707;PF08246;PF12895;PF13405;PF13519;PF13589;PF13639
Group	GO:0006461	protein complex assembly	2	7.54	1.00e-10	2.02e-09	45|324|180|3527	PF00019;PF00041;PF00063;PF00093;PF00094;PF00130;PF00168;PF00169;PF00179;PF00289;PF00350;PF00400;PF00452;PF00515;PF00564;PF00611;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01302;PF01391;PF01826;PF02148;PF02181;PF02214;PF02263;PF02771;PF03165;PF04695;PF06309;PF06367;PF06371;PF07645;PF07651;PF07654;PF07679;PF08515;PF08742;PF12763;PF12947;PF13405
Group	GO:0009968	negative regulation of signal transduction	2	7.55	1.31e-10	2.58e-09	42|324|162|3527	PF00019;PF00041;PF00049;PF00057;PF00093;PF00130;PF00168;PF00169;PF00373;PF00400;PF00651;PF00683;PF00688;PF00778;PF00884;PF01302;PF01391;PF01392;PF01448;PF01585;PF01833;PF02145;PF02210;PF02214;PF02865;PF03165;PF03226;PF03920;PF07525;PF07645;PF07679;PF09289;PF09379;PF09380;PF10409;PF12548;PF12763;PF12796;PF13405;PF13639;PF13855;PF14324
Group	GO:2000145	regulation of cell motility	2	7.73	2.19e-10	4.22e-09	32|324|104|3527	PF00019;PF00041;PF00045;PF00086;PF00090;PF00093;PF00130;PF00168;PF00373;PF00413;PF00688;PF00757;PF00884;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02185;PF07546;PF07645;PF07653;PF07679;PF08246;PF10409;PF12548;PF13716;PF13855
Group	GO:0035107	appendage morphogenesis	2	7.73	3.04e-10	5.75e-09	30|324|94|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00307;PF00373;PF00435;PF00452;PF00651;PF00884;PF01064;PF01369;PF01400;PF01426;PF01448;PF01476;PF01833;PF03165;PF03826;PF07534;PF07645;PF07679;PF08515;PF09379;PF12045;PF12548;PF12796;PF13855;PF14259
Group	GO:0007292	female gamete generation	2	7.63	9.06e-10	1.64e-08	26|324|76|3527	PF00063;PF00076;PF00106;PF00130;PF00168;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00564;PF00618;PF00622;PF00651;PF00667;PF01064;PF01562;PF03165;PF07525;PF07653;PF07679;PF07686;PF08515;PF14259
Group	GO:0018193	peptidyl-amino acid modification	2	7.14	1.11e-09	1.97e-08	39|324|153|3527	PF00041;PF00054;PF00085;PF00130;PF00168;PF00169;PF00240;PF00254;PF00258;PF00373;PF00400;PF00535;PF00557;PF00583;PF00611;PF00667;PF00754;PF00757;PF00899;PF01030;PF01302;PF01753;PF02210;PF02518;PF02865;PF03062;PF03133;PF04389;PF04810;PF05033;PF07645;PF07647;PF07679;PF11717;PF12796;PF13733;PF13831;PF13832;PF13855
Group	GO:0051216	cartilage development	2	7.99	1.23e-09	2.12e-08	19|324|43|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00093;PF00688;PF00884;PF01064;PF01391;PF02210;PF03165;PF03826;PF07645;PF07679;PF08515;PF10524;PF12045;PF12548
Group	GO:0044057	regulation of system process	2	7.18	1.82e-09	3.06e-08	33|324|118|3527	PF00019;PF00027;PF00041;PF00063;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00435;PF00618;PF00667;PF00688;PF00689;PF00690;PF00702;PF01391;PF01699;PF01833;PF02210;PF02214;PF02931;PF03226;PF07653;PF07679;PF07686;PF10608;PF11933;PF12796;PF13426;PF13855;PF13857
Group	GO:0001763	morphogenesis of a branching structure	2	7.53	2.01e-09	3.32e-08	24|324|68|3527	PF00019;PF00045;PF00049;PF00090;PF00130;PF00307;PF00413;PF00435;PF00564;PF00688;PF00754;PF01064;PF01403;PF01437;PF01471;PF01833;PF07645;PF07653;PF07679;PF08246;PF08447;PF08515;PF12045;PF13855
Group	GO:0030155	regulation of cell adhesion	2	7.37	2.08e-09	3.36e-08	27|324|84|3527	PF00019;PF00041;PF00063;PF00086;PF00093;PF00130;PF00149;PF00168;PF00169;PF00373;PF00651;PF00688;PF00754;PF01064;PF01369;PF01391;PF01392;PF01421;PF01562;PF02865;PF07645;PF07653;PF07679;PF08515;PF10409;PF11971;PF13716
Group	GO:0048737	imaginal disc-derived appendage development	2	7.54	2.94e-09	4.61e-08	22|324|59|3527	PF00063;PF00076;PF00130;PF00307;PF00373;PF00435;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF08515;PF09379;PF12796;PF13855;PF14259
Group	GO:0050817	coagulation	2	7.48	2.95e-09	4.61e-08	23|324|64|3527	PF00024;PF00027;PF00041;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01826;PF01841;PF06920;PF07679;PF07686;PF08742;PF14429
Group	GO:0007411	axon guidance	2	7.30	3.21e-09	4.86e-08	26|324|80|3527	PF00041;PF00052;PF00307;PF00435;PF00651;PF00754;PF00778;PF00780;PF01064;PF01391;PF01400;PF01403;PF01437;PF01833;PF02148;PF02177;PF02210;PF03165;PF03953;PF07645;PF07679;PF08515;PF08736;PF10524;PF12924;PF13855
Group	GO:0048569	post-embryonic organ development	2	7.22	3.16e-09	4.86e-08	28|324|91|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01064;PF01369;PF01400;PF01426;PF01448;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08515;PF09379;PF12796;PF13855;PF14259
Group	GO:0035239	tube morphogenesis	2	7.01	4.78e-09	7.10e-08	31|324|110|3527	PF00019;PF00045;PF00049;PF00090;PF00130;PF00168;PF00307;PF00400;PF00413;PF00435;PF00564;PF00651;PF00688;PF00754;PF00989;PF01391;PF01392;PF01403;PF01437;PF01471;PF02145;PF03165;PF05033;PF07653;PF07679;PF07686;PF07707;PF08246;PF08447;PF12045;PF13855
Group	GO:0051241	negative regulation of multicellular organismal process	2	7.19	8.24e-09	1.19e-07	23|324|67|3527	PF00019;PF00041;PF00086;PF00122;PF00169;PF00240;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01391;PF01699;PF02865;PF02931;PF06741;PF07525;PF07645;PF07654;PF10409;PF12796;PF13857
Group	GO:0034330	cell junction organization	2	7.19	8.24e-09	1.19e-07	23|324|67|3527	PF00019;PF00041;PF00052;PF00053;PF00130;PF00168;PF00169;PF00307;PF00373;PF00435;PF00564;PF00688;PF01044;PF01391;PF02210;PF02828;PF07645;PF07653;PF07679;PF07686;PF09379;PF09380;PF13903
Group	GO:0007268	synaptic transmission	2	6.61	1.35e-08	1.88e-07	36|324|146|3527	PF00041;PF00063;PF00122;PF00130;PF00168;PF00169;PF00435;PF00622;PF00651;PF00690;PF00928;PF01044;PF01064;PF01217;PF01302;PF01392;PF01602;PF02177;PF02210;PF02214;PF02828;PF02931;PF03165;PF07647;PF07653;PF07679;PF07690;PF07707;PF08515;PF10600;PF10608;PF12763;PF12796;PF12924;PF13426;PF13855
Group	GO:0016337	cell-cell adhesion	2	7.22	1.73e-08	2.38e-07	19|324|49|3527	PF00041;PF00054;PF00059;PF00122;PF00169;PF00373;PF00688;PF00689;PF00690;PF00702;PF00884;PF02210;PF07679;PF07686;PF09058;PF10600;PF10608;PF12548;PF13855
Group	GO:0006468	protein phosphorylation	2	6.51	2.42e-08	3.28e-07	34|324|136|3527	PF00019;PF00027;PF00041;PF00049;PF00063;PF00130;PF00168;PF00169;PF00240;PF00373;PF00564;PF00611;PF00688;PF00754;PF00757;PF00780;PF00989;PF01030;PF01064;PF02177;PF02185;PF02518;PF02865;PF03165;PF04868;PF07645;PF07647;PF07653;PF07679;PF08515;PF08926;PF12924;PF13426;PF13855
Group	GO:0050878	regulation of body fluid levels	2	6.76	2.84e-08	3.79e-07	25|324|82|3527	PF00024;PF00027;PF00041;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01553;PF01826;PF01841;PF02865;PF06920;PF07679;PF07686;PF08742;PF14429
Group	GO:0007346	regulation of mitotic cell cycle	2	6.61	3.25e-08	4.28e-07	28|324|100|3527	PF00019;PF00076;PF00130;PF00168;PF00270;PF00271;PF00452;PF00515;PF00688;PF01426;PF01448;PF02148;PF02177;PF02865;PF06733;PF07653;PF07679;PF07686;PF09058;PF10600;PF10608;PF11934;PF12796;PF12895;PF12924;PF13086;PF13639;PF14324
Group	GO:0043549	regulation of kinase activity	2	6.26	7.14e-08	9.25e-07	33|324|135|3527	PF00019;PF00027;PF00041;PF00049;PF00097;PF00169;PF00240;PF00400;PF00415;PF00564;PF00688;PF00778;PF00780;PF01391;PF01392;PF01585;PF02145;PF02177;PF02210;PF02931;PF04868;PF07525;PF07645;PF07653;PF07679;PF09379;PF09380;PF11934;PF12796;PF12924;PF13405;PF13716;PF13855
Group	GO:0032880	regulation of protein localization	2	6.52	7.71e-08	9.85e-07	24|324|80|3527	PF00019;PF00020;PF00059;PF00085;PF00097;PF00307;PF00564;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01392;PF02204;PF02210;PF07654;PF07686;PF12796;PF13405;PF13716;PF13855
Group	GO:0051130	positive regulation of cellular component organization	2	6.36	8.26e-08	1.04e-06	28|324|104|3527	PF00019;PF00041;PF00059;PF00168;PF00241;PF00400;PF00452;PF00515;PF00611;PF00688;PF01064;PF01302;PF01391;PF01403;PF01437;PF02181;PF02185;PF02210;PF03165;PF06367;PF06371;PF07653;PF07679;PF07686;PF08515;PF12796;PF13637;PF13855
Group	GO:0035556	intracellular signal transduction	2	6.05	9.15e-08	1.14e-06	40|324|184|3527	PF00027;PF00041;PF00049;PF00063;PF00122;PF00130;PF00149;PF00168;PF00169;PF00240;PF00270;PF00400;PF00435;PF00452;PF00564;PF00610;PF00611;PF00618;PF00651;PF00689;PF00690;PF00702;PF00780;PF01302;PF01412;PF02145;PF02185;PF02759;PF02865;PF07525;PF07645;PF07647;PF07653;PF07679;PF08246;PF10409;PF11971;PF12763;PF13716;PF13855
Group	GO:0006909	phagocytosis	2	6.72	1.12e-07	1.37e-06	18|324|49|3527	PF00041;PF00053;PF00057;PF00059;PF00106;PF00130;PF00400;PF01033;PF01217;PF01391;PF01426;PF01448;PF01562;PF07546;PF07645;PF07679;PF07686;PF11971
Group	GO:0007018	microtubule-based movement	2	6.53	1.41e-07	1.71e-06	20|324|60|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01302;PF01602;PF02177;PF03133;PF07728;PF08393;PF08447;PF12774;PF12775;PF12780;PF12924;PF13405
Group	GO:0060341	regulation of cellular localization	2	6.02	1.61e-07	1.92e-06	34|324|146|3527	PF00019;PF00020;PF00027;PF00059;PF00063;PF00076;PF00085;PF00097;PF00168;PF00169;PF00307;PF00349;PF00610;PF00618;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01302;PF01391;PF01392;PF01833;PF02214;PF02931;PF04810;PF07654;PF07686;PF12796;PF13405;PF13716;PF13855
Group	GO:0045786	negative regulation of cell cycle	2	6.46	2.13e-07	2.51e-06	19|324|56|3527	PF00019;PF00106;PF00270;PF00271;PF00350;PF00605;PF00688;PF01477;PF02148;PF06733;PF07645;PF07653;PF07679;PF09058;PF10409;PF10600;PF10608;PF11934;PF13086
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	6.18	3.29e-07	3.82e-06	22|324|74|3527	PF00019;PF00020;PF00041;PF00049;PF00122;PF00130;PF00179;PF00240;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF01391;PF01485;PF02218;PF07653;PF07679;PF12763
Group	GO:0007015	actin filament organization	2	6.25	3.51e-07	3.89e-06	20|324|63|3527	PF00063;PF00241;PF00307;PF00373;PF00400;PF00611;PF01064;PF02181;PF02214;PF06367;PF06371;PF07653;PF08515;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF12796
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	6.25	3.51e-07	3.89e-06	20|324|63|3527	PF00019;PF00041;PF00086;PF00307;PF00435;PF00515;PF00688;PF00780;PF01403;PF01437;PF01562;PF01833;PF02181;PF02210;PF02931;PF03165;PF06367;PF06371;PF07679;PF13855
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	6.08	3.52e-07	3.89e-06	24|324|86|3527	PF00027;PF00041;PF00063;PF00130;PF00168;PF00169;PF00226;PF00307;PF00610;PF00611;PF00618;PF00780;PF01403;PF01412;PF01437;PF02145;PF02204;PF06920;PF07647;PF07653;PF11971;PF13716;PF13855;PF14429
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	6.08	3.52e-07	3.89e-06	24|324|86|3527	PF00019;PF00041;PF00049;PF00130;PF00168;PF00169;PF00307;PF00618;PF00688;PF00754;PF00757;PF00884;PF01030;PF02145;PF02865;PF07525;PF07645;PF07647;PF07653;PF07679;PF07686;PF10409;PF12548;PF13855
Group	GO:0007610	behavior	2	5.80	3.82e-07	4.17e-06	34|324|151|3527	PF00027;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00307;PF00435;PF00530;PF00564;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01369;PF01421;PF01465;PF01562;PF01699;PF02177;PF02210;PF02214;PF02865;PF02931;PF07653;PF11933;PF12796;PF12924;PF13639;PF13716;PF13855
Group	GO:0008283	cell proliferation	2	5.78	4.41e-07	4.76e-06	33|324|145|3527	PF00019;PF00020;PF00027;PF00041;PF00076;PF00086;PF00130;PF00254;PF00452;PF00501;PF00530;PF00564;PF00688;PF01064;PF01392;PF01433;PF02148;PF02198;PF02865;PF03165;PF03826;PF05485;PF07653;PF07679;PF07686;PF08506;PF08515;PF09058;PF10409;PF10600;PF10608;PF12874;PF13639
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	6.40	4.74e-07	5.06e-06	16|324|43|3527	PF00019;PF00086;PF00090;PF00093;PF00094;PF00683;PF00688;PF00884;PF01064;PF01392;PF03165;PF07645;PF08515;PF09289;PF12548;PF12796
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	5.71	6.01e-07	6.20e-06	32|324|140|3527	PF00019;PF00041;PF00049;PF00057;PF00076;PF00179;PF00240;PF00373;PF00400;PF00515;PF00564;PF00688;PF00757;PF00778;PF00780;PF01030;PF01064;PF01302;PF01391;PF02204;PF02210;PF02218;PF02931;PF04868;PF07645;PF07653;PF07679;PF08515;PF12763;PF13405;PF13855;PF14324
Group	GO:0048610	cellular process involved in reproduction	2	5.56	6.40e-07	6.52e-06	40|324|197|3527	PF00019;PF00041;PF00063;PF00076;PF00130;PF00149;PF00168;PF00179;PF00240;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00452;PF00564;PF00622;PF00651;PF00688;PF01064;PF01562;PF01751;PF01753;PF02518;PF02865;PF02931;PF03165;PF04408;PF05033;PF07525;PF07647;PF07653;PF07679;PF07686;PF08515;PF12796;PF13589;PF13857;PF14259
Group	GO:0001654	eye development	2	5.78	6.71e-07	6.76e-06	28|324|114|3527	PF00019;PF00041;PF00053;PF00063;PF00130;PF00168;PF00373;PF00400;PF00415;PF00452;PF00564;PF00618;PF00651;PF00688;PF01064;PF01392;PF01602;PF02210;PF02865;PF03826;PF07679;PF08515;PF08736;PF09379;PF09380;PF10409;PF13716;PF14324
Group	GO:0007600	sensory perception	2	5.80	8.44e-07	8.41e-06	25|324|96|3527	PF00024;PF00027;PF00053;PF00063;PF00106;PF00122;PF00307;PF00350;PF00373;PF00415;PF00689;PF00690;PF00702;PF01391;PF01477;PF02931;PF07653;PF07679;PF07686;PF09379;PF10600;PF12796;PF13385;PF13637;PF13857
Group	GO:0051235	maintenance of location	2	6.34	9.00e-07	8.78e-06	14|324|35|3527	PF00122;PF00241;PF00307;PF00400;PF00435;PF00683;PF00689;PF00690;PF00702;PF01044;PF07645;PF11971;PF12756;PF12796
Group	GO:0008360	regulation of cell shape	2	5.99	9.70e-07	9.29e-06	19|324|61|3527	PF00024;PF00063;PF00130;PF00169;PF00373;PF00611;PF00618;PF00780;PF01403;PF01437;PF02181;PF06367;PF06371;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409
Group	GO:0001568	blood vessel development	2	5.73	9.73e-07	9.29e-06	26|324|103|3527	PF00019;PF00063;PF00090;PF00093;PF00106;PF00168;PF00169;PF00373;PF00530;PF00618;PF00688;PF01064;PF01392;PF01403;PF01433;PF01437;PF01833;PF02198;PF02210;PF02434;PF07645;PF07679;PF07686;PF08515;PF12796;PF13716
Group	GO:0045597	positive regulation of cell differentiation	2	5.67	1.28e-06	1.21e-05	25|324|98|3527	PF00019;PF00041;PF00086;PF00090;PF00093;PF00130;PF00168;PF00400;PF00530;PF00564;PF00688;PF01064;PF01391;PF01403;PF01437;PF02198;PF02865;PF03165;PF07525;PF07645;PF07679;PF12045;PF12796;PF13405;PF13855
Group	GO:0046903	secretion	2	5.61	1.32e-06	1.23e-05	27|324|111|3527	PF00019;PF00027;PF00041;PF00063;PF00122;PF00130;PF00168;PF00169;PF00610;PF00618;PF00683;PF00688;PF00702;PF00928;PF01217;PF01553;PF01602;PF02210;PF02828;PF02865;PF02931;PF06046;PF07645;PF07647;PF07651;PF07679;PF12763
Group	GO:0034762	regulation of transmembrane transport	2	5.74	1.45e-06	1.33e-05	22|324|80|3527	PF00019;PF00085;PF00168;PF00254;PF00307;PF00622;PF00688;PF00757;PF00778;PF01030;PF01302;PF01391;PF01392;PF02210;PF07647;PF07653;PF12796;PF13405;PF13637;PF13716;PF13855;PF13903
Group	GO:0044087	regulation of cellular component biogenesis	2	5.61	1.45e-06	1.33e-05	26|324|105|3527	PF00041;PF00063;PF00086;PF00130;PF00168;PF00241;PF00307;PF00373;PF00400;PF00452;PF00611;PF00622;PF01064;PF01302;PF01392;PF02181;PF02210;PF02518;PF03165;PF06367;PF06371;PF07647;PF07653;PF08515;PF10409;PF12796
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	5.61	1.58e-06	1.43e-05	25|324|99|3527	PF00019;PF00041;PF00049;PF00054;PF00057;PF00240;PF00564;PF00688;PF00778;PF00780;PF01064;PF01302;PF01391;PF01392;PF01403;PF02210;PF02218;PF02931;PF04868;PF07645;PF07653;PF07679;PF08515;PF12763;PF13855
Group	GO:0048732	gland development	2	5.67	1.83e-06	1.61e-05	22|324|81|3527	PF00041;PF00049;PF00122;PF00702;PF00754;PF00757;PF00989;PF01030;PF01391;PF01403;PF01553;PF01562;PF02198;PF02210;PF02865;PF03826;PF07679;PF07686;PF08515;PF08736;PF10409;PF13716
Group	GO:0072657	protein localization to membrane	2	6.07	2.00e-06	1.74e-05	14|324|37|3527	PF00053;PF00054;PF00169;PF00611;PF01391;PF01392;PF02210;PF07653;PF07679;PF10600;PF10608;PF12796;PF13405;PF13637
Group	GO:0021700	developmental maturation	2	5.67	2.31e-06	1.99e-05	20|324|70|3527	PF00019;PF00041;PF00076;PF00130;PF00169;PF00435;PF00564;PF00622;PF00651;PF00688;PF01833;PF02177;PF03953;PF07525;PF07679;PF10608;PF12796;PF12924;PF13855;PF14259
Group	GO:0001558	regulation of cell growth	2	5.59	2.94e-06	2.47e-05	20|324|71|3527	PF00019;PF00041;PF00086;PF00179;PF00226;PF00307;PF00435;PF00688;PF00754;PF00757;PF01030;PF01088;PF01403;PF01437;PF01562;PF02210;PF07679;PF10409;PF12796;PF13855
Group	GO:0044092	negative regulation of molecular function	2	5.15	4.88e-06	4.02e-05	31|324|146|3527	PF00041;PF00076;PF00086;PF00168;PF00169;PF00254;PF00258;PF00307;PF00373;PF00400;PF00452;PF00667;PF00688;PF01302;PF01391;PF01585;PF02145;PF02148;PF02210;PF07258;PF07525;PF07653;PF09324;PF09379;PF09380;PF10600;PF10608;PF11934;PF12796;PF13405;PF13716
Group	GO:0030163	protein catabolic process	2	5.17	6.37e-06	5.20e-05	26|324|113|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00400;PF00452;PF00515;PF00622;PF00789;PF01485;PF01841;PF02148;PF02214;PF03256;PF03953;PF05020;PF05021;PF07707;PF09409;PF12895;PF13519;PF13589;PF13639
Group	GO:0051640	organelle localization	2	5.20	6.75e-06	5.47e-05	24|324|100|3527	PF00063;PF00130;PF00168;PF00169;PF00307;PF00350;PF00400;PF00435;PF00515;PF00651;PF00780;PF01302;PF01403;PF02181;PF03953;PF04810;PF07707;PF07728;PF08393;PF12756;PF12774;PF12775;PF12780;PF13405
Group	GO:0048638	regulation of developmental growth	2	5.33	7.58e-06	6.09e-05	19|324|69|3527	PF00019;PF00063;PF00179;PF00307;PF00435;PF00611;PF00622;PF00688;PF01064;PF01392;PF01403;PF01437;PF01562;PF02210;PF03165;PF07679;PF08515;PF13405;PF13855
Group	GO:0007009	plasma membrane organization	2	5.62	8.59e-06	6.72e-05	13|324|36|3527	PF00054;PF00063;PF00168;PF00169;PF00307;PF00435;PF00611;PF00622;PF01391;PF02210;PF12796;PF13405;PF13637
Group	GO:0009798	axis specification	2	5.43	8.55e-06	6.72e-05	16|324|52|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00400;PF00564;PF00622;PF00651;PF00778;PF01064;PF03165;PF05033;PF07525;PF08515;PF14259
Group	GO:0001817	regulation of cytokine production	2	5.21	8.77e-06	6.80e-05	21|324|82|3527	PF00019;PF00020;PF00059;PF00076;PF00130;PF00240;PF00271;PF00605;PF00622;PF00642;PF00651;PF00688;PF00969;PF01391;PF02023;PF02865;PF02931;PF07654;PF07686;PF12796;PF13855
Group	GO:0051301	cell division	2	5.14	9.04e-06	6.95e-05	23|324|95|3527	PF00019;PF00063;PF00076;PF00130;PF00169;PF00241;PF00271;PF00307;PF00350;PF00435;PF00452;PF00564;PF00651;PF00688;PF00780;PF01064;PF02181;PF03165;PF03953;PF06367;PF06371;PF07707;PF08515
Group	GO:0010975	regulation of neuron projection development	2	5.29	9.58e-06	7.24e-05	18|324|64|3527	PF00041;PF00254;PF00307;PF00435;PF00611;PF00780;PF01403;PF01437;PF01562;PF01833;PF02181;PF02931;PF06367;PF06371;PF07679;PF10409;PF12796;PF13855
Group	GO:0032844	regulation of homeostatic process	2	5.25	9.55e-06	7.24e-05	19|324|70|3527	PF00019;PF00041;PF00057;PF00168;PF00179;PF00254;PF00307;PF00452;PF00622;PF00688;PF00969;PF02198;PF02865;PF03226;PF07654;PF12796;PF13405;PF13637;PF13716
Group	GO:0048705	skeletal system morphogenesis	2	5.43	9.98e-06	7.48e-05	15|324|47|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00688;PF00884;PF01391;PF02210;PF03165;PF07645;PF07679;PF08515;PF12045;PF12548
Group	GO:0030097	hemopoiesis	2	5.05	1.03e-05	7.63e-05	25|324|109|3527	PF00019;PF00041;PF00063;PF00130;PF00153;PF00169;PF00452;PF00605;PF00651;PF00688;PF00780;PF01392;PF02218;PF02865;PF05790;PF07645;PF07654;PF07679;PF07686;PF11971;PF12796;PF13637;PF13855;PF13857;PF14324
Group	GO:0032535	regulation of cellular component size	2	5.21	1.22e-05	8.96e-05	18|324|65|3527	PF00041;PF00130;PF00168;PF00169;PF00241;PF00307;PF00400;PF00435;PF01403;PF01437;PF01562;PF02145;PF02181;PF02210;PF07653;PF07679;PF10409;PF13855
Group	GO:0010942	positive regulation of cell death	2	4.96	1.25e-05	9.15e-05	26|324|117|3527	PF00019;PF00020;PF00041;PF00090;PF00169;PF00240;PF00270;PF00271;PF00307;PF00452;PF00605;PF00688;PF01302;PF01335;PF01391;PF01392;PF01585;PF02865;PF06733;PF07647;PF07653;PF07679;PF08246;PF08515;PF10409;PF13716
Group	GO:0010564	regulation of cell cycle process	2	4.94	1.26e-05	9.17e-05	27|324|124|3527	PF00019;PF00076;PF00130;PF00149;PF00168;PF00240;PF00270;PF00271;PF00400;PF00452;PF00515;PF00688;PF01336;PF01426;PF01448;PF02148;PF02185;PF04005;PF06733;PF07679;PF07686;PF11934;PF12796;PF12895;PF13086;PF13639;PF14324
Group	GO:0072347	response to anesthetic	2	6.45	1.37e-05	9.58e-05	6|324|8|3527	PF00052;PF00053;PF00054;PF00057;PF02210;PF07679
Group	GO:0045199	maintenance of epithelial cell apical/basal polarity	2	6.45	1.37e-05	9.58e-05	6|324|8|3527	PF00052;PF00053;PF00054;PF00057;PF02210;PF07679
Group	GO:0071310	cellular response to organic substance	2	4.71	1.37e-05	9.58e-05	42|324|237|3527	PF00019;PF00020;PF00041;PF00049;PF00076;PF00093;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00400;PF00452;PF00583;PF00605;PF00622;PF00688;PF00754;PF00757;PF00969;PF01030;PF01064;PF01179;PF01391;PF01909;PF02263;PF02518;PF02865;PF03165;PF07525;PF07653;PF07654;PF07679;PF07686;PF08515;PF10409;PF13639;PF13855
Group	GO:0008038	neuron recognition	2	5.71	1.44e-05	9.96e-05	10|324|23|3527	PF00041;PF00307;PF00435;PF00651;PF01400;PF01437;PF02177;PF07647;PF07679;PF12924
Group	GO:0050808	synapse organization	2	5.34	1.53e-05	1.03e-04	14|324|43|3527	PF00063;PF00130;PF00564;PF00690;PF01392;PF02177;PF02210;PF07653;PF07679;PF10600;PF10608;PF12796;PF12924;PF13857
Group	GO:0060348	bone development	2	5.34	1.53e-05	1.03e-04	14|324|43|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00622;PF00688;PF00884;PF01391;PF02210;PF07645;PF07679;PF12045;PF12548
Group	GO:0060560	developmental growth involved in morphogenesis	2	5.18	1.53e-05	1.03e-04	17|324|60|3527	PF00019;PF00041;PF00057;PF00130;PF00688;PF01064;PF01391;PF02177;PF02828;PF07653;PF07679;PF08515;PF08736;PF12796;PF12924;PF13855;PF13857
Group	GO:0051051	negative regulation of transport	2	5.18	1.53e-05	1.03e-04	17|324|60|3527	PF00019;PF00130;PF00168;PF00258;PF00307;PF00400;PF00611;PF00622;PF00667;PF00688;PF01064;PF01302;PF01391;PF01833;PF12796;PF13405;PF13716
Group	GO:0051240	positive regulation of multicellular organismal process	2	4.96	1.57e-05	1.05e-04	23|324|98|3527	PF00019;PF00027;PF00054;PF00122;PF00130;PF00168;PF00169;PF00271;PF00605;PF00688;PF00689;PF00690;PF00702;PF01064;PF01391;PF01699;PF02210;PF02865;PF07645;PF07679;PF12796;PF13716;PF13855
Group	GO:0000279	M phase	2	4.83	1.71e-05	1.12e-04	28|324|133|3527	PF00130;PF00149;PF00179;PF00240;PF00270;PF00271;PF00307;PF00385;PF00400;PF00651;PF00780;PF01751;PF02148;PF02518;PF03953;PF04408;PF07647;PF07679;PF07686;PF07707;PF08393;PF12765;PF12775;PF12780;PF12796;PF12895;PF13589;PF13857
Group	GO:0048511	rhythmic process	2	5.15	1.90e-05	1.24e-04	16|324|55|3527	PF00019;PF00027;PF00041;PF00076;PF00452;PF00583;PF00688;PF00989;PF01392;PF01421;PF02518;PF02865;PF02931;PF07679;PF08447;PF13716
Group	GO:2000027	regulation of organ morphogenesis	2	5.10	1.95e-05	1.24e-04	17|324|61|3527	PF00019;PF00086;PF00400;PF00452;PF00610;PF00688;PF00778;PF00884;PF01064;PF01392;PF02377;PF03165;PF07679;PF08515;PF10524;PF12548;PF12796
Group	GO:0043269	regulation of ion transport	2	4.95	1.95e-05	1.24e-04	21|324|86|3527	PF00122;PF00168;PF00169;PF00254;PF00258;PF00307;PF00435;PF00452;PF00622;PF00667;PF00689;PF00690;PF00702;PF02210;PF07647;PF07653;PF07690;PF12796;PF13405;PF13426;PF13903
Group	GO:0080135	regulation of cellular response to stress	2	4.95	1.95e-05	1.24e-04	21|324|86|3527	PF00020;PF00040;PF00041;PF00049;PF00059;PF00097;PF00149;PF00168;PF00169;PF00179;PF00270;PF00271;PF00452;PF00778;PF00780;PF01392;PF01753;PF06733;PF07653;PF13639;PF13855
Group	GO:0051050	positive regulation of transport	2	4.90	2.11e-05	1.34e-04	22|324|93|3527	PF00019;PF00040;PF00049;PF00059;PF00076;PF00168;PF00169;PF00307;PF00349;PF00400;PF00452;PF00688;PF00969;PF01302;PF01391;PF02210;PF07647;PF07654;PF07686;PF12796;PF13405;PF13855
Group	GO:0008285	negative regulation of cell proliferation	2	4.85	2.24e-05	1.41e-04	23|324|100|3527	PF00019;PF00350;PF00373;PF00688;PF00754;PF00884;PF00969;PF01391;PF01753;PF02145;PF02865;PF03165;PF07654;PF07679;PF07686;PF09379;PF09380;PF10409;PF10524;PF10608;PF12548;PF13716;PF13733
Group	GO:0023061	signal release	2	5.01	2.46e-05	1.53e-04	17|324|62|3527	PF00019;PF00027;PF00063;PF00130;PF00168;PF00169;PF00610;PF00618;PF00683;PF00688;PF00928;PF01217;PF01602;PF02210;PF02828;PF07645;PF12763
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	5.12	2.75e-05	1.69e-04	14|324|45|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01602;PF02177;PF03953;PF08447;PF12924;PF13405
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	4.98	3.11e-05	1.89e-04	16|324|57|3527	PF00019;PF00041;PF00057;PF00400;PF00688;PF00778;PF00884;PF01302;PF01391;PF01392;PF07679;PF12548;PF12796;PF13637;PF13639;PF13857
Group	GO:0000278	mitotic cell cycle	2	4.61	3.63e-05	2.18e-04	27|324|131|3527	PF00019;PF00130;PF00179;PF00270;PF00271;PF00400;PF00452;PF00688;PF00780;PF01336;PF01833;PF02148;PF02177;PF03953;PF04499;PF07679;PF07686;PF07728;PF08393;PF12765;PF12774;PF12775;PF12780;PF12842;PF12895;PF12924;PF14324
Group	GO:0016331	morphogenesis of embryonic epithelium	2	4.86	3.86e-05	2.30e-04	17|324|64|3527	PF00063;PF00130;PF00373;PF00564;PF01064;PF01392;PF02145;PF02185;PF02828;PF07647;PF07653;PF07679;PF08515;PF08736;PF09379;PF09380;PF12796
Group	GO:0051347	positive regulation of transferase activity	2	4.76	4.18e-05	2.48e-04	19|324|77|3527	PF00019;PF00041;PF00049;PF00057;PF00169;PF00240;PF00400;PF00564;PF00688;PF00778;PF00780;PF01391;PF02210;PF02931;PF04868;PF07645;PF07653;PF07679;PF13855
Group	GO:0016569	covalent chromatin modification	2	4.54	5.09e-05	3.00e-04	25|324|119|3527	PF00076;PF00097;PF00130;PF00168;PF00179;PF00254;PF00385;PF00400;PF00515;PF00530;PF00583;PF00622;PF01088;PF01426;PF01448;PF01753;PF02008;PF02148;PF05033;PF11717;PF12796;PF13415;PF13831;PF13832;PF13857
Group	GO:0055123	digestive system development	2	4.91	5.69e-05	3.31e-04	13|324|42|3527	PF00019;PF00041;PF00049;PF00400;PF00688;PF00757;PF01030;PF01392;PF03165;PF03826;PF07647;PF07679;PF07686
Group	GO:0031589	cell-substrate adhesion	2	4.92	6.60e-05	3.81e-04	12|324|37|3527	PF00041;PF00086;PF00094;PF01391;PF01392;PF01826;PF06119;PF07645;PF07647;PF07686;PF08742;PF13637
Group	GO:0001822	kidney development	2	4.62	6.74e-05	3.87e-04	18|324|73|3527	PF00019;PF00041;PF00240;PF00400;PF00452;PF00651;PF00688;PF00884;PF01391;PF02434;PF02865;PF07679;PF07707;PF08246;PF10162;PF12548;PF13716;PF13857
Group	GO:0003002	regionalization	2	4.39	7.26e-05	4.04e-04	27|324|136|3527	PF00019;PF00041;PF00057;PF00063;PF00076;PF00093;PF00130;PF00168;PF00385;PF00400;PF00622;PF00651;PF00688;PF00778;PF01064;PF01392;PF01448;PF02008;PF02377;PF03165;PF05033;PF07525;PF07679;PF08515;PF12045;PF12796;PF13857
Group	GO:0045927	positive regulation of growth	2	4.65	7.73e-05	4.28e-04	16|324|61|3527	PF00063;PF00133;PF00168;PF00169;PF00270;PF00271;PF00757;PF00989;PF01030;PF01064;PF02865;PF03165;PF08515;PF12796;PF13405;PF13716
Group	GO:0050678	regulation of epithelial cell proliferation	2	4.68	7.97e-05	4.33e-04	15|324|55|3527	PF00019;PF00041;PF00130;PF00168;PF00688;PF00757;PF00884;PF01030;PF01064;PF02865;PF03165;PF07679;PF08515;PF10524;PF12548
Group	GO:0032970	regulation of actin filament-based process	2	4.68	7.97e-05	4.33e-04	15|324|55|3527	PF00041;PF00086;PF00130;PF00168;PF00169;PF00241;PF00373;PF00400;PF00610;PF00611;PF02181;PF07647;PF07653;PF07686;PF12796
Group	GO:0051248	negative regulation of protein metabolic process	2	4.40	7.87e-05	4.33e-04	25|324|122|3527	PF00019;PF00041;PF00076;PF00226;PF00240;PF00307;PF00373;PF00400;PF00452;PF00688;PF00789;PF01335;PF01391;PF01585;PF02145;PF02148;PF05773;PF07525;PF09379;PF09380;PF11934;PF12796;PF13405;PF13716;PF14259
Group	GO:0008544	epidermis development	2	4.56	8.18e-05	4.41e-04	18|324|74|3527	PF00019;PF00063;PF00093;PF00122;PF00373;PF00400;PF00622;PF00688;PF00689;PF00702;PF00757;PF01030;PF01391;PF01392;PF06733;PF07679;PF12796;PF13855
Group	GO:0036075	replacement ossification	2	5.19	8.95e-05	4.75e-04	8|324|18|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00688;PF02210;PF07679
Group	GO:0060249	anatomical structure homeostasis	2	4.45	9.28e-05	4.89e-04	20|324|88|3527	PF00041;PF00059;PF00082;PF00270;PF00271;PF00373;PF00435;PF00452;PF01336;PF01391;PF02023;PF06733;PF07679;PF07686;PF08246;PF08736;PF09379;PF09380;PF12796;PF13857
Group	GO:0050776	regulation of immune response	2	4.36	9.35e-05	4.90e-04	24|324|116|3527	PF00041;PF00057;PF00059;PF00090;PF00130;PF00168;PF00169;PF00179;PF00240;PF00611;PF00651;PF00754;PF00969;PF01391;PF01476;PF02865;PF07534;PF07645;PF07654;PF07679;PF07686;PF08246;PF13639;PF13855
Group	GO:0006955	immune response	2	4.22	1.22e-04	6.20e-04	27|324|140|3527	PF00041;PF00057;PF00059;PF00085;PF00090;PF00130;PF00240;PF00271;PF00350;PF00605;PF00651;PF00969;PF01033;PF01391;PF02263;PF02865;PF07645;PF07654;PF07679;PF07686;PF08246;PF10409;PF11971;PF12697;PF12796;PF13639;PF13855
Group	GO:0060627	regulation of vesicle-mediated transport	2	4.51	1.25e-04	6.27e-04	15|324|57|3527	PF00059;PF00168;PF00169;PF00400;PF00610;PF00611;PF00618;PF01302;PF01391;PF01833;PF02145;PF02210;PF07645;PF07651;PF07686
Group	GO:0006066	alcohol metabolic process	2	4.34	1.30e-04	6.49e-04	20|324|90|3527	PF00019;PF00027;PF00057;PF00109;PF00205;PF00432;PF00501;PF00535;PF00688;PF00698;PF01066;PF01663;PF02177;PF02801;PF03062;PF03765;PF04116;PF07645;PF08659;PF12924
Group	GO:0042981	regulation of apoptotic process	2	4.04	1.43e-04	7.07e-04	39|324|236|3527	PF00019;PF00020;PF00024;PF00041;PF00049;PF00082;PF00086;PF00090;PF00130;PF00168;PF00169;PF00240;PF00270;PF00271;PF00307;PF00452;PF00564;PF00605;PF00688;PF00757;PF01030;PF01064;PF01302;PF01335;PF01391;PF01392;PF01585;PF02865;PF06733;PF07647;PF07653;PF07679;PF08246;PF08515;PF10409;PF12763;PF13405;PF13716;PF13855
Group	GO:0050890	cognition	2	4.43	1.54e-04	7.56e-04	15|324|58|3527	PF00057;PF00122;PF00530;PF00564;PF00689;PF00690;PF00702;PF01699;PF02177;PF02210;PF02931;PF07653;PF12924;PF13639;PF13716
Group	GO:0042391	regulation of membrane potential	2	4.29	1.70e-04	8.10e-04	18|324|78|3527	PF00041;PF00169;PF00452;PF01421;PF01562;PF02023;PF02210;PF02214;PF02931;PF07653;PF07679;PF07686;PF10600;PF10608;PF11933;PF12796;PF13637;PF13716
Group	GO:0007283	spermatogenesis	2	4.29	1.70e-04	8.10e-04	18|324|78|3527	PF00041;PF00063;PF00179;PF00226;PF00240;PF00270;PF00350;PF00452;PF00651;PF00780;PF01421;PF01562;PF01753;PF04408;PF07647;PF07679;PF12796;PF14259
Group	GO:0002252	immune effector process	2	4.22	1.79e-04	8.31e-04	20|324|92|3527	PF00041;PF00057;PF00059;PF00090;PF00130;PF00270;PF00271;PF00605;PF00969;PF01391;PF01909;PF02138;PF07645;PF07654;PF07679;PF07686;PF08246;PF10409;PF13639;PF13855
Group	GO:0001738	morphogenesis of a polarized epithelium	2	4.60	2.10e-04	9.72e-04	10|324|30|3527	PF00053;PF00063;PF00130;PF00168;PF00564;PF00651;PF02210;PF02828;PF10600;PF10608
Group	GO:0050865	regulation of cell activation	2	4.17	2.39e-04	1.09e-03	18|324|80|3527	PF00019;PF00020;PF00041;PF00059;PF00086;PF00130;PF00168;PF00605;PF00611;PF00651;PF00688;PF00969;PF02865;PF05790;PF07653;PF07654;PF07686;PF13405
Group	GO:0007498	mesoderm development	2	4.46	2.43e-04	1.10e-03	11|324|36|3527	PF00019;PF00307;PF00373;PF00435;PF00688;PF01064;PF03165;PF08515;PF09379;PF09380;PF13426
Group	GO:0032101	regulation of response to external stimulus	2	4.11	2.43e-04	1.10e-03	20|324|94|3527	PF00019;PF00020;PF00027;PF00041;PF00130;PF00168;PF00688;PF00754;PF01391;PF01403;PF01421;PF01437;PF01562;PF01833;PF02210;PF02865;PF07653;PF07679;PF13405;PF13855
Group	GO:0016049	cell growth	2	4.29	2.49e-04	1.12e-03	14|324|54|3527	PF00041;PF00130;PF00651;PF01064;PF02177;PF07679;PF07707;PF08515;PF08736;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0045765	regulation of angiogenesis	2	4.32	2.58e-04	1.14e-03	13|324|48|3527	PF00041;PF00090;PF00093;PF00130;PF00168;PF00169;PF00884;PF02865;PF07645;PF08246;PF12548;PF12947;PF13716
Group	GO:0048562	embryonic organ morphogenesis	2	4.32	2.58e-04	1.14e-03	13|324|48|3527	PF00052;PF00054;PF00063;PF00122;PF00689;PF00690;PF00702;PF01392;PF02210;PF03165;PF03826;PF07679;PF08515
Group	GO:0032446	protein modification by small protein conjugation	2	4.03	2.57e-04	1.14e-03	23|324|116|3527	PF00097;PF00168;PF00179;PF00240;PF00415;PF00622;PF00651;PF00899;PF01485;PF02148;PF02214;PF02225;PF03256;PF05773;PF07707;PF12796;PF12894;PF12895;PF12906;PF13637;PF13639;PF13857;PF14324
Group	GO:0030900	forebrain development	2	4.11	2.82e-04	1.22e-03	18|324|81|3527	PF00019;PF00041;PF00057;PF00688;PF00757;PF01030;PF01064;PF02177;PF02210;PF03165;PF03826;PF07645;PF07647;PF07679;PF10524;PF12924;PF13716;PF13855
Group	GO:0051345	positive regulation of hydrolase activity	2	4.06	2.83e-04	1.22e-03	20|324|95|3527	PF00019;PF00041;PF00063;PF00130;PF00168;PF00169;PF00226;PF00452;PF00610;PF00611;PF00688;PF01412;PF02145;PF02204;PF02865;PF06920;PF07679;PF08246;PF13716;PF14429
Group	GO:0048706	embryonic skeletal system development	2	4.60	3.25e-04	1.33e-03	8|324|21|3527	PF00052;PF00053;PF00054;PF00884;PF02210;PF03165;PF08515;PF12548
Group	GO:0006304	DNA modification	2	4.28	3.29e-04	1.33e-03	12|324|43|3527	PF00270;PF00271;PF01426;PF02008;PF04408;PF05033;PF06464;PF07647;PF08210;PF12047;PF12796;PF13857
Group	GO:0060173	limb development	2	4.28	3.29e-04	1.33e-03	12|324|43|3527	PF00019;PF00057;PF00168;PF00452;PF00688;PF00884;PF01448;PF03165;PF03826;PF07679;PF12045;PF12548
Group	GO:0016358	dendrite development	2	4.23	3.23e-04	1.33e-03	13|324|49|3527	PF00024;PF00041;PF00053;PF00307;PF00435;PF00780;PF01044;PF01064;PF02177;PF07653;PF07679;PF12796;PF12924
Group	GO:0040029	regulation of gene expression, epigenetic	2	4.05	3.31e-04	1.33e-03	18|324|82|3527	PF00179;PF00270;PF00271;PF00385;PF00400;PF01088;PF01426;PF02008;PF04408;PF05033;PF06464;PF07647;PF08210;PF12047;PF12796;PF13086;PF13638;PF13857
Group	GO:0045165	cell fate commitment	2	3.99	3.19e-04	1.33e-03	21|324|103|3527	PF00019;PF00076;PF00130;PF00307;PF00349;PF00435;PF00564;PF00651;PF00688;PF00989;PF01064;PF01465;PF01562;PF02828;PF03165;PF07645;PF07653;PF07679;PF08515;PF10409;PF12045
Group	GO:0002684	positive regulation of immune system process	2	3.94	3.34e-04	1.33e-03	23|324|118|3527	PF00020;PF00041;PF00057;PF00059;PF00086;PF00090;PF00130;PF00168;PF00169;PF00179;PF00240;PF00611;PF00651;PF00969;PF01391;PF01476;PF02865;PF05790;PF07534;PF07645;PF07654;PF07686;PF13855
Group	GO:0007369	gastrulation	2	4.13	3.75e-04	1.49e-03	14|324|56|3527	PF00019;PF00076;PF00130;PF00168;PF00307;PF00373;PF00435;PF00583;PF00688;PF00778;PF01064;PF03165;PF09379;PF09380
Group	GO:0032259	methylation	2	3.99	3.88e-04	1.54e-03	18|324|83|3527	PF00076;PF00271;PF00385;PF00400;PF00515;PF00622;PF01189;PF01426;PF01585;PF01753;PF02008;PF04408;PF05033;PF06464;PF07647;PF12047;PF12796;PF13857
Group	GO:0030003	cellular cation homeostasis	2	3.89	4.01e-04	1.58e-03	22|324|112|3527	PF00041;PF00122;PF00130;PF00168;PF00254;PF00400;PF00452;PF00530;PF00622;PF00689;PF00690;PF00702;PF01496;PF01699;PF02177;PF02225;PF02931;PF04389;PF07690;PF12710;PF12924;PF13405
Group	GO:0051494	negative regulation of cytoskeleton organization	2	4.24	4.12e-04	1.61e-03	11|324|38|3527	PF00041;PF00086;PF00241;PF00254;PF00307;PF00400;PF00435;PF00622;PF01302;PF07653;PF12796
Group	GO:0002697	regulation of immune effector process	2	4.05	4.13e-04	1.61e-03	15|324|63|3527	PF00020;PF00041;PF00059;PF00097;PF00168;PF00169;PF00611;PF00651;PF00754;PF01217;PF01602;PF02865;PF07654;PF07686;PF13855
Group	GO:0017038	protein import	2	4.05	4.13e-04	1.61e-03	15|324|63|3527	PF00019;PF00226;PF00400;PF00515;PF00675;PF00688;PF02064;PF02145;PF02865;PF03810;PF04695;PF05193;PF07645;PF12796;PF13513
Group	GO:0006605	protein targeting	2	3.85	4.31e-04	1.67e-03	23|324|120|3527	PF00019;PF00168;PF00226;PF00307;PF00432;PF00435;PF00515;PF00675;PF00688;PF02064;PF02145;PF02865;PF02985;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF12796;PF13405;PF13513;PF13855
Group	GO:0051046	regulation of secretion	2	3.90	4.37e-04	1.69e-03	20|324|98|3527	PF00019;PF00020;PF00027;PF00040;PF00059;PF00097;PF00168;PF00169;PF00349;PF00610;PF00618;PF00622;PF00688;PF00969;PF01064;PF01833;PF02214;PF02931;PF07654;PF07686
Group	GO:0031532	actin cytoskeleton reorganization	2	4.58	4.47e-04	1.70e-03	7|324|17|3527	PF00122;PF00130;PF00689;PF00690;PF00702;PF00780;PF07686
Group	GO:0043408	regulation of MAPK cascade	2	3.93	4.53e-04	1.71e-03	18|324|84|3527	PF00020;PF00049;PF00097;PF00130;PF00168;PF00169;PF00373;PF00757;PF00778;PF00780;PF01030;PF01391;PF01392;PF07653;PF07679;PF09379;PF09380;PF13855
Group	GO:0060485	mesenchyme development	2	4.05	4.57e-04	1.72e-03	14|324|57|3527	PF00019;PF00530;PF00688;PF00754;PF00757;PF01030;PF01064;PF01392;PF01403;PF01833;PF02865;PF07645;PF07679;PF08515
Group	GO:0006913	nucleocytoplasmic transport	2	3.93	5.19e-04	1.93e-03	16|324|71|3527	PF00019;PF00076;PF00270;PF00271;PF00688;PF01412;PF02145;PF02865;PF02985;PF03810;PF07645;PF08389;PF08506;PF12796;PF13405;PF13513
Group	GO:0030001	metal ion transport	2	3.73	5.78e-04	2.09e-03	24|324|130|3527	PF00027;PF00041;PF00085;PF00122;PF00153;PF00168;PF00254;PF00622;PF00651;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF02225;PF02931;PF04389;PF07686;PF07690;PF07707;PF11933;PF12796;PF13426
Group	GO:0006898	receptor-mediated endocytosis	2	4.22	5.95e-04	2.12e-03	9|324|28|3527	PF00040;PF00057;PF00059;PF00169;PF00350;PF00611;PF07645;PF07651;PF12947
Group	GO:0044265	cellular macromolecule catabolic process	2	3.60	6.76e-04	2.36e-03	31|324|187|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00271;PF00400;PF00452;PF00515;PF00622;PF00642;PF00789;PF01485;PF01909;PF02148;PF02214;PF03256;PF03953;PF05020;PF05021;PF07707;PF12842;PF12895;PF13086;PF13519;PF13589;PF13638;PF13639;PF14259
Group	GO:0034621	cellular macromolecular complex subunit organization	2	3.61	6.90e-04	2.40e-03	29|324|171|3527	PF00019;PF00041;PF00063;PF00076;PF00130;PF00168;PF00169;PF00179;PF00241;PF00270;PF00271;PF00307;PF00400;PF00583;PF00611;PF00642;PF00688;PF01064;PF01302;PF01585;PF02181;PF03165;PF06367;PF06371;PF07651;PF07679;PF08515;PF12874;PF14259
Group	GO:0015672	monovalent inorganic cation transport	2	3.83	7.98e-04	2.71e-03	14|324|60|3527	PF00027;PF00153;PF00651;PF00690;PF00702;PF01496;PF01699;PF02214;PF07686;PF07690;PF07707;PF11933;PF13426;PF13637
Group	GO:0051052	regulation of DNA metabolic process	2	3.74	8.44e-04	2.84e-03	16|324|74|3527	PF00019;PF00149;PF00179;PF00270;PF00271;PF00515;PF00651;PF00688;PF01336;PF01391;PF01751;PF06733;PF07679;PF12756;PF12895;PF13086
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	3.54	8.39e-04	2.84e-03	29|324|173|3527	PF00019;PF00020;PF00049;PF00400;PF00435;PF00651;PF00688;PF00989;PF01833;PF02177;PF02865;PF03165;PF03920;PF04762;PF04818;PF07500;PF07645;PF07679;PF08447;PF08711;PF08788;PF10524;PF11934;PF12796;PF12924;PF13415;PF13716;PF13854;PF13857
Group	GO:0045596	negative regulation of cell differentiation	2	3.62	8.51e-04	2.85e-03	22|324|118|3527	PF00019;PF00086;PF00307;PF00515;PF00605;PF00642;PF00688;PF00778;PF00780;PF01064;PF01391;PF01403;PF02177;PF02865;PF03165;PF07645;PF07679;PF08515;PF12796;PF12924;PF13716;PF14259
Group	GO:0010608	posttranscriptional regulation of gene expression	2	3.62	8.51e-04	2.85e-03	22|324|118|3527	PF00019;PF00076;PF00240;PF00270;PF00271;PF00307;PF00642;PF00757;PF01030;PF02148;PF02177;PF02985;PF05773;PF07973;PF08246;PF08662;PF10409;PF12924;PF13086;PF13405;PF13638;PF14259
Group	GO:0007519	skeletal muscle tissue development	2	3.75	9.52e-04	3.13e-03	14|324|61|3527	PF00041;PF00049;PF00622;PF01369;PF01392;PF01562;PF02177;PF03826;PF06920;PF07679;PF07686;PF12796;PF12924;PF13857
Group	GO:0007548	sex differentiation	2	3.68	9.85e-04	3.20e-03	16|324|75|3527	PF00019;PF00041;PF00076;PF00270;PF00271;PF00400;PF00452;PF00651;PF00688;PF00989;PF01064;PF01392;PF01421;PF02865;PF07679;PF07686
Group	GO:0009725	response to hormone stimulus	2	3.51	1.03e-03	3.34e-03	25|324|143|3527	PF00019;PF00041;PF00045;PF00049;PF00130;PF00169;PF00307;PF00413;PF00452;PF00515;PF00688;PF00757;PF01030;PF01064;PF01391;PF01471;PF01554;PF02218;PF02518;PF02865;PF07525;PF07653;PF10409;PF13639;PF13855
Group	GO:0042176	regulation of protein catabolic process	2	3.84	1.05e-03	3.38e-03	11|324|42|3527	PF00240;PF00307;PF00373;PF00400;PF00515;PF00778;PF00789;PF01335;PF02148;PF07525;PF14324
Group	GO:0033365	protein localization to organelle	2	3.52	1.16e-03	3.70e-03	21|324|113|3527	PF00019;PF00168;PF00226;PF00240;PF00307;PF00350;PF00435;PF00515;PF00675;PF00688;PF02064;PF02145;PF02865;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF12796;PF13513
Group	GO:0008284	positive regulation of cell proliferation	2	3.47	1.31e-03	4.15e-03	21|324|114|3527	PF00019;PF00020;PF00041;PF00049;PF00086;PF00130;PF00168;PF00564;PF00651;PF00688;PF00757;PF00884;PF01030;PF01064;PF02218;PF02865;PF03826;PF07679;PF07686;PF08246;PF12548
Group	GO:0055065	metal ion homeostasis	2	3.49	1.41e-03	4.41e-03	18|324|92|3527	PF00041;PF00122;PF00130;PF00168;PF00254;PF00452;PF00530;PF00622;PF00689;PF00690;PF00702;PF02177;PF02225;PF02931;PF04389;PF07690;PF12710;PF12924
Group	GO:0043583	ear development	2	3.65	1.44e-03	4.50e-03	12|324|50|3527	PF00049;PF00063;PF00122;PF00400;PF00689;PF00690;PF00702;PF01392;PF07645;PF07654;PF07679;PF13385
Group	GO:0009100	glycoprotein metabolic process	2	3.44	1.69e-03	5.26e-03	17|324|86|3527	PF00049;PF00085;PF00094;PF00122;PF00515;PF00534;PF00535;PF00702;PF00884;PF01841;PF02210;PF02434;PF04810;PF09409;PF12548;PF13733;PF13855
Group	GO:0006952	defense response	2	3.27	1.75e-03	5.42e-03	29|324|181|3527	PF00020;PF00041;PF00057;PF00059;PF00085;PF00130;PF00240;PF00270;PF00271;PF00350;PF00501;PF00605;PF00969;PF01033;PF01302;PF01391;PF01476;PF01909;PF02263;PF02865;PF05790;PF07534;PF07654;PF07686;PF10409;PF12697;PF12947;PF13639;PF13855
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	3.57	1.93e-03	5.82e-03	11|324|45|3527	PF00122;PF00179;PF00240;PF00689;PF00690;PF00702;PF01391;PF01485;PF02865;PF12796;PF13405
Group	GO:0042063	gliogenesis	2	3.42	2.47e-03	7.21e-03	12|324|53|3527	PF00049;PF00169;PF00757;PF01030;PF01421;PF01562;PF02865;PF03165;PF07679;PF10524;PF13716;PF13903
Group	GO:0019216	regulation of lipid metabolic process	2	3.35	2.49e-03	7.26e-03	14|324|67|3527	PF00019;PF00041;PF00049;PF00097;PF00169;PF00400;PF00501;PF00688;PF01391;PF02865;PF07653;PF07679;PF11934;PF12697
Group	GO:0012501	programmed cell death	2	3.17	2.54e-03	7.39e-03	24|324|144|3527	PF00027;PF00090;PF00130;PF00240;PF00349;PF00452;PF00564;PF00651;PF00757;PF00989;PF01030;PF01335;PF02177;PF02865;PF07647;PF07653;PF08246;PF08447;PF10409;PF12874;PF12924;PF13405;PF13716;PF13855
Group	GO:0071495	cellular response to endogenous stimulus	2	3.19	2.56e-03	7.43e-03	22|324|128|3527	PF00019;PF00041;PF00049;PF00093;PF00168;PF00169;PF00307;PF00452;PF00688;PF00757;PF01030;PF01064;PF01179;PF01391;PF02518;PF02865;PF07653;PF07679;PF08515;PF10409;PF13639;PF13855
Group	GO:0016311	dephosphorylation	2	3.40	2.81e-03	7.99e-03	11|324|47|3527	PF00041;PF00149;PF00373;PF00702;PF04818;PF07679;PF08736;PF09379;PF09380;PF10409;PF13344
Group	GO:0040017	positive regulation of locomotion	2	3.34	2.91e-03	8.05e-03	12|324|54|3527	PF00019;PF00053;PF00090;PF00093;PF00130;PF00168;PF00169;PF00373;PF00688;PF01562;PF07679;PF08246
Group	GO:0009416	response to light stimulus	2	3.12	3.13e-03	8.56e-03	21|324|122|3527	PF00057;PF00076;PF00122;PF00226;PF00271;PF00400;PF00452;PF00689;PF00690;PF00702;PF00989;PF02177;PF02518;PF02931;PF06733;PF08447;PF12924;PF13426;PF13716;PF13855;PF13857
Group	GO:0048285	organelle fission	2	3.22	3.32e-03	9.01e-03	14|324|69|3527	PF00085;PF00307;PF00350;PF00385;PF00400;PF00452;PF00515;PF00780;PF01751;PF02148;PF03953;PF05033;PF12765;PF12895
Group	GO:0030855	epithelial cell differentiation	2	3.22	3.32e-03	9.01e-03	14|324|69|3527	PF00019;PF00024;PF00041;PF00049;PF00130;PF00688;PF01064;PF01392;PF02198;PF02865;PF03165;PF07645;PF07679;PF10524
Group	GO:0007422	peripheral nervous system development	2	3.40	3.41e-03	9.24e-03	9|324|35|3527	PF00019;PF00041;PF00169;PF00757;PF01030;PF01421;PF01562;PF07679;PF13716
Group	GO:0070482	response to oxygen levels	2	3.27	3.43e-03	9.25e-03	12|324|55|3527	PF00019;PF00045;PF00413;PF00530;PF00534;PF00688;PF00989;PF01471;PF02145;PF02931;PF08447;PF13716
Group	GO:0045893	positive regulation of transcription, DNA-dependent	2	3.02	3.68e-03	9.49e-03	24|324|148|3527	PF00019;PF00020;PF00400;PF00435;PF00605;PF00688;PF00757;PF00989;PF01030;PF01833;PF02177;PF02865;PF03165;PF03826;PF07645;PF08210;PF08313;PF08447;PF08788;PF10524;PF12796;PF12924;PF13405;PF13716
Group	GO:0040023	establishment of nucleus localization	3	6.87	5.07e-07	5.35e-06	11|324|21|3527	PF00130;PF00307;PF00435;PF00780;PF01302;PF03953;PF07728;PF08393;PF12774;PF12775;PF12780
Group	GO:0051017	actin filament bundle assembly	3	6.55	8.76e-07	8.63e-06	12|324|26|3527	PF00063;PF00307;PF00373;PF00611;PF02181;PF02214;PF06367;PF06371;PF07653;PF09379;PF09380;PF12796
Group	GO:0045186	zonula adherens assembly	3	7.13	1.59e-06	1.43e-05	7|324|9|3527	PF00130;PF00169;PF00307;PF00435;PF00564;PF02828;PF07653
Group	GO:0001935	endothelial cell proliferation	3	6.90	1.66e-06	1.48e-05	8|324|12|3527	PF00019;PF00530;PF00688;PF05485;PF07653;PF09058;PF10600;PF10608
Group	GO:0002028	regulation of sodium ion transport	3	6.53	2.68e-06	2.27e-05	9|324|16|3527	PF00122;PF00168;PF00169;PF00307;PF00435;PF00689;PF00690;PF00702;PF13405
Group	GO:0045639	positive regulation of myeloid cell differentiation	3	6.22	8.55e-06	6.72e-05	8|324|14|3527	PF00019;PF00130;PF00168;PF00688;PF02198;PF02865;PF12796;PF13405
Group	GO:0030703	eggshell formation	3	6.45	1.37e-05	9.58e-05	6|324|8|3527	PF00168;PF00385;PF00622;PF01064;PF07525;PF08515
Group	GO:0007391	dorsal closure	3	5.78	1.68e-05	1.11e-04	9|324|19|3527	PF00063;PF00373;PF01064;PF02185;PF08515;PF08736;PF09379;PF09380;PF12796
Group	GO:0001894	tissue homeostasis	3	5.53	2.27e-05	1.42e-04	10|324|24|3527	PF00059;PF00082;PF00373;PF00452;PF01391;PF07686;PF08246;PF08736;PF09379;PF09380
Group	GO:0030199	collagen fibril organization	3	5.90	2.74e-05	1.69e-04	7|324|12|3527	PF00093;PF00530;PF01391;PF01421;PF01562;PF08515;PF13716
Group	GO:0045822	negative regulation of heart contraction	3	6.29	3.53e-05	2.13e-04	5|324|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0006901	vesicle coating	3	5.58	5.46e-05	3.20e-04	7|324|13|3527	PF00611;PF00651;PF00928;PF01217;PF01602;PF07651;PF07707
Group	GO:0048840	otolith development	3	6.29	7.00e-05	3.92e-04	4|324|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	6.29	7.00e-05	3.92e-04	4|324|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032468	Golgi calcium ion homeostasis	3	6.29	7.00e-05	3.92e-04	4|324|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0071766	Actinobacterium-type cell wall biogenesis	3	5.57	8.77e-05	4.71e-04	6|324|10|3527	PF00106;PF00109;PF00501;PF00698;PF02801;PF08659
Group	GO:0022405	hair cycle process	3	5.19	8.95e-05	4.75e-04	8|324|18|3527	PF00019;PF00688;PF00757;PF01030;PF01391;PF01392;PF02210;PF07679
Group	GO:0051897	positive regulation of protein kinase B signaling cascade	3	5.30	1.01e-04	5.25e-04	7|324|14|3527	PF00019;PF00049;PF00688;PF00757;PF01030;PF07653;PF12763
Group	GO:0030010	establishment of cell polarity	3	4.99	1.07e-04	5.46e-04	9|324|23|3527	PF00041;PF00130;PF00169;PF00373;PF00400;PF00564;PF01302;PF01369;PF09379
Group	GO:0042157	lipoprotein metabolic process	3	4.99	1.07e-04	5.46e-04	9|324|23|3527	PF00057;PF00149;PF00534;PF00535;PF01302;PF01663;PF03062;PF07645;PF12796
Group	GO:0030336	negative regulation of cell migration	3	4.99	1.07e-04	5.46e-04	9|324|23|3527	PF00019;PF00086;PF00688;PF00884;PF01391;PF07546;PF10409;PF12548;PF13855
Group	GO:0035147	branch fusion, open tracheal system	3	5.71	1.14e-04	5.82e-04	5|324|7|3527	PF00307;PF00435;PF07653;PF08447;PF13855
Group	GO:0042476	odontogenesis	3	4.98	1.42e-04	7.06e-04	8|324|19|3527	PF00019;PF00373;PF00688;PF01064;PF01391;PF07679;PF09379;PF09380
Group	GO:0007565	female pregnancy	3	4.82	1.57e-04	7.57e-04	9|324|24|3527	PF00045;PF00053;PF00106;PF00413;PF00754;PF01335;PF01471;PF02865;PF07686
Group	GO:0007088	regulation of mitosis	3	4.82	1.57e-04	7.57e-04	9|324|24|3527	PF00019;PF00270;PF00271;PF00515;PF00688;PF02148;PF07679;PF07686;PF12895
Group	GO:0050796	regulation of insulin secretion	3	4.82	1.57e-04	7.57e-04	9|324|24|3527	PF00019;PF00027;PF00168;PF00349;PF00688;PF00969;PF01064;PF02214;PF07654
Group	GO:0010827	regulation of glucose transport	3	5.04	1.74e-04	8.22e-04	7|324|15|3527	PF00049;PF00130;PF00168;PF00169;PF01302;PF01391;PF12796
Group	GO:0003156	regulation of organ formation	3	5.04	1.74e-04	8.22e-04	7|324|15|3527	PF00019;PF00688;PF00884;PF01064;PF03165;PF08515;PF12548
Group	GO:0002026	regulation of the force of heart contraction	3	5.22	1.78e-04	8.31e-04	6|324|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0048640	negative regulation of developmental growth	3	5.22	1.78e-04	8.31e-04	6|324|11|3527	PF00019;PF00611;PF00622;PF00688;PF01403;PF02210
Group	GO:0045930	negative regulation of mitotic cell cycle	3	4.78	2.19e-04	1.01e-03	8|324|20|3527	PF00270;PF00271;PF06733;PF07653;PF09058;PF10600;PF10608;PF13086
Group	GO:0006984	ER-nucleus signaling pathway	3	4.66	2.26e-04	1.03e-03	9|324|25|3527	PF00049;PF00085;PF00122;PF00226;PF00400;PF00689;PF00690;PF00702;PF13639
Group	GO:0030638	polyketide metabolic process	3	5.23	2.82e-04	1.22e-03	5|324|8|3527	PF00109;PF00698;PF02801;PF08242;PF08659
Group	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	3	5.23	2.82e-04	1.22e-03	5|324|8|3527	PF00040;PF00059;PF00270;PF00271;PF01753
Group	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	3	4.80	2.85e-04	1.22e-03	7|324|16|3527	PF00019;PF00041;PF00049;PF00169;PF00688;PF07653;PF07679
Group	GO:0042462	eye photoreceptor cell development	3	4.80	2.85e-04	1.22e-03	7|324|16|3527	PF00063;PF00168;PF00415;PF00651;PF02210;PF08736;PF10409
Group	GO:0034311	diol metabolic process	3	4.80	2.85e-04	1.22e-03	7|324|16|3527	PF00019;PF00109;PF00501;PF00688;PF00698;PF02801;PF08659
Group	GO:1901185	negative regulation of ERBB signaling pathway	3	4.80	2.85e-04	1.22e-03	7|324|16|3527	PF00041;PF00168;PF01448;PF01585;PF07525;PF07679;PF13855
Group	GO:0051238	sequestering of metal ion	3	5.49	3.25e-04	1.33e-03	4|324|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0055071	manganese ion homeostasis	3	5.49	3.25e-04	1.33e-03	4|324|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0045646	regulation of erythrocyte differentiation	3	4.90	3.29e-04	1.33e-03	6|324|12|3527	PF00019;PF00307;PF00688;PF02198;PF02865;PF12796
Group	GO:0018958	phenol-containing compound metabolic process	3	4.60	3.25e-04	1.33e-03	8|324|21|3527	PF00019;PF00109;PF00501;PF00688;PF00698;PF02801;PF04389;PF08659
Group	GO:0007601	visual perception	3	4.36	4.39e-04	1.69e-03	9|324|27|3527	PF00027;PF00053;PF00063;PF00106;PF00350;PF00415;PF02931;PF13385;PF13857
Group	GO:0050920	regulation of chemotaxis	3	4.58	4.47e-04	1.70e-03	7|324|17|3527	PF00019;PF00688;PF01403;PF01437;PF01833;PF02210;PF07653
Group	GO:0007309	oocyte axis specification	3	4.58	4.47e-04	1.70e-03	7|324|17|3527	PF00076;PF00130;PF00564;PF00622;PF00651;PF07525;PF14259
Group	GO:0060491	regulation of cell projection assembly	3	4.43	4.71e-04	1.76e-03	8|324|22|3527	PF00063;PF00086;PF00130;PF02181;PF02518;PF06367;PF06371;PF12796
Group	GO:0018108	peptidyl-tyrosine phosphorylation	3	4.43	4.71e-04	1.76e-03	8|324|22|3527	PF00041;PF00373;PF00611;PF00754;PF02865;PF07645;PF07647;PF07679
Group	GO:0001666	response to hypoxia	3	4.09	5.21e-04	1.93e-03	12|324|45|3527	PF00019;PF00045;PF00413;PF00530;PF00534;PF00688;PF00989;PF01471;PF02145;PF02931;PF08447;PF13716
Group	GO:0008542	visual learning	3	4.62	5.64e-04	2.06e-03	6|324|13|3527	PF00122;PF00689;PF00690;PF00702;PF02177;PF12924
Group	GO:0007520	myoblast fusion	3	4.62	5.64e-04	2.06e-03	6|324|13|3527	PF00041;PF01369;PF06920;PF07679;PF07686;PF12796
Group	GO:0007179	transforming growth factor beta receptor signaling pathway	3	4.62	5.64e-04	2.06e-03	6|324|13|3527	PF00106;PF00683;PF01064;PF07645;PF08515;PF12874
Group	GO:0048009	insulin-like growth factor receptor signaling pathway	3	4.82	5.86e-04	2.09e-03	5|324|9|3527	PF00049;PF00169;PF00757;PF01030;PF02145
Group	GO:0006611	protein export from nucleus	3	4.82	5.86e-04	2.09e-03	5|324|9|3527	PF00019;PF00688;PF03810;PF08389;PF13405
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	4.82	5.86e-04	2.09e-03	5|324|9|3527	PF00122;PF00689;PF00690;PF00702;PF02210
Group	GO:0032776	DNA methylation on cytosine	3	4.82	5.86e-04	2.09e-03	5|324|9|3527	PF01426;PF02008;PF06464;PF12047;PF12796
Group	GO:0032092	positive regulation of protein binding	3	4.82	5.86e-04	2.09e-03	5|324|9|3527	PF00373;PF02434;PF08736;PF09379;PF09380
Group	GO:0016525	negative regulation of angiogenesis	3	4.26	6.65e-04	2.34e-03	8|324|23|3527	PF00041;PF00090;PF00093;PF00884;PF02865;PF07645;PF12548;PF12947
Group	GO:0046165	alcohol biosynthetic process	3	4.26	6.65e-04	2.34e-03	8|324|23|3527	PF00019;PF00109;PF00205;PF00688;PF00698;PF02801;PF04116;PF08659
Group	GO:0007173	epidermal growth factor receptor signaling pathway	3	4.26	6.65e-04	2.34e-03	8|324|23|3527	PF00019;PF00130;PF00168;PF00169;PF00688;PF00757;PF01030;PF07645
Group	GO:0045807	positive regulation of endocytosis	3	4.37	6.75e-04	2.36e-03	7|324|18|3527	PF00059;PF00168;PF00400;PF01302;PF01391;PF02210;PF07686
Group	GO:0007561	imaginal disc eversion	3	5.45	7.69e-04	2.63e-03	3|324|3|3527	PF00045;PF00413;PF01471
Group	GO:0045834	positive regulation of lipid metabolic process	3	4.09	7.94e-04	2.71e-03	9|324|29|3527	PF00019;PF00041;PF00049;PF00169;PF00688;PF01391;PF07653;PF07679;PF12697
Group	GO:0031333	negative regulation of protein complex assembly	3	4.37	9.11e-04	3.02e-03	6|324|14|3527	PF00130;PF00241;PF00307;PF01302;PF02181;PF12796
Group	GO:0002695	negative regulation of leukocyte activation	3	4.37	9.11e-04	3.02e-03	6|324|14|3527	PF00019;PF00605;PF00651;PF00688;PF00969;PF07654
Group	GO:0008358	maternal determination of anterior/posterior axis, embryo	3	4.37	9.11e-04	3.02e-03	6|324|14|3527	PF00076;PF00622;PF00651;PF01064;PF07525;PF08515
Group	GO:0017145	stem cell division	3	4.11	9.19e-04	3.03e-03	8|324|24|3527	PF00019;PF00076;PF00130;PF00564;PF00688;PF01064;PF03165;PF08515
Group	GO:0009636	response to toxin	3	4.18	9.86e-04	3.20e-03	7|324|19|3527	PF00122;PF00452;PF00702;PF00989;PF02931;PF08447;PF11933
Group	GO:0031345	negative regulation of cell projection organization	3	4.18	9.86e-04	3.20e-03	7|324|19|3527	PF00041;PF00086;PF00254;PF00780;PF01403;PF02210;PF13855
Group	GO:0070664	negative regulation of leukocyte proliferation	3	4.47	1.08e-03	3.46e-03	5|324|10|3527	PF00019;PF00688;PF00969;PF07654;PF07686
Group	GO:0043171	peptide catabolic process	3	4.47	1.08e-03	3.46e-03	5|324|10|3527	PF00082;PF00557;PF01433;PF04389;PF08246
Group	GO:0008624	induction of apoptosis by extracellular signals	3	4.47	1.08e-03	3.46e-03	5|324|10|3527	PF00020;PF00169;PF00307;PF01335;PF07653
Group	GO:0060840	artery development	3	4.14	1.40e-03	4.40e-03	6|324|15|3527	PF00019;PF00106;PF00688;PF01064;PF08515;PF13716
Group	GO:0006885	regulation of pH	3	4.01	1.40e-03	4.40e-03	7|324|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF01496;PF13405
Group	GO:0045931	positive regulation of mitotic cell cycle	3	4.01	1.40e-03	4.40e-03	7|324|20|3527	PF00130;PF00168;PF01426;PF01448;PF02177;PF02865;PF12924
Group	GO:0042181	ketone biosynthetic process	3	4.17	1.84e-03	5.62e-03	5|324|11|3527	PF00109;PF00698;PF02801;PF08242;PF08659
Group	GO:0008586	imaginal disc-derived wing vein morphogenesis	3	4.17	1.84e-03	5.62e-03	5|324|11|3527	PF00063;PF01400;PF01448;PF07645;PF14259
Group	GO:0051568	histone H3-K4 methylation	3	4.17	1.84e-03	5.62e-03	5|324|11|3527	PF00076;PF00400;PF00515;PF00622;PF02008
Group	GO:0032321	positive regulation of Rho GTPase activity	3	4.17	1.84e-03	5.62e-03	5|324|11|3527	PF00041;PF00063;PF00611;PF06920;PF14429
Group	GO:0051291	protein heterooligomerization	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF00041;PF00757;PF01030;PF01391
Group	GO:0006301	postreplication repair	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF00179;PF00400;PF00817;PF11799
Group	GO:0035215	genital disc development	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF01064;PF07679;PF07686;PF08515
Group	GO:0006828	manganese ion transport	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0070050	neuron homeostasis	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF00041;PF07679;PF12796;PF13857
Group	GO:0031638	zymogen activation	3	4.40	1.96e-03	5.82e-03	4|324|7|3527	PF00045;PF00413;PF01471;PF08246
Group	GO:0002831	regulation of response to biotic stimulus	3	3.84	1.94e-03	5.82e-03	7|324|21|3527	PF00130;PF00168;PF01217;PF01602;PF07686;PF12796;PF13855
Group	GO:0006937	regulation of muscle contraction	3	3.93	2.07e-03	6.11e-03	6|324|16|3527	PF00122;PF00689;PF00690;PF00702;PF02931;PF07686
Group	GO:0022602	ovulation cycle process	3	3.93	2.07e-03	6.11e-03	6|324|16|3527	PF00019;PF00452;PF00688;PF01392;PF01421;PF02865
Group	GO:0010464	regulation of mesenchymal cell proliferation	3	3.93	2.07e-03	6.11e-03	6|324|16|3527	PF00019;PF00688;PF03165;PF03826;PF07679;PF10524
Group	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3	3.69	2.17e-03	6.37e-03	8|324|27|3527	PF00130;PF00168;PF00169;PF00564;PF00899;PF12796;PF13405;PF13855
Group	GO:0007416	synapse assembly	3	3.69	2.62e-03	7.56e-03	7|324|22|3527	PF00063;PF00130;PF00564;PF02177;PF02210;PF07653;PF12924
Group	GO:0070734	histone H3-K27 methylation	3	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF05033;PF12796;PF13857
Group	GO:0046777	protein autophosphorylation	3	3.57	2.80e-03	7.99e-03	8|324|28|3527	PF00041;PF00063;PF00757;PF00989;PF01030;PF02518;PF07647;PF13426
Group	GO:0006275	regulation of DNA replication	3	3.57	2.80e-03	7.99e-03	8|324|28|3527	PF00019;PF00271;PF00515;PF00688;PF01336;PF12756;PF12895;PF13086
Group	GO:0046887	positive regulation of hormone secretion	3	3.90	2.92e-03	8.05e-03	5|324|12|3527	PF00019;PF00349;PF00688;PF00969;PF07654
Group	GO:0008582	regulation of synaptic growth at neuromuscular junction	3	3.90	2.92e-03	8.05e-03	5|324|12|3527	PF00622;PF01064;PF01392;PF03165;PF08515
Group	GO:0019954	asexual reproduction	3	3.90	2.92e-03	8.05e-03	5|324|12|3527	PF00063;PF00169;PF00618;PF02518;PF09335
Group	GO:0010923	negative regulation of phosphatase activity	3	3.74	2.96e-03	8.11e-03	6|324|17|3527	PF00076;PF00254;PF07653;PF10600;PF10608;PF13405
Group	GO:0031331	positive regulation of cellular catabolic process	3	3.74	2.96e-03	8.11e-03	6|324|17|3527	PF00271;PF00400;PF00642;PF00778;PF12697;PF13855
Group	GO:0043900	regulation of multi-organism process	3	3.54	3.47e-03	9.35e-03	7|324|23|3527	PF00130;PF00168;PF00605;PF01217;PF01602;PF12796;PF13855
Group	GO:0090175	regulation of establishment of planar polarity	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00610;PF00778;PF01392;PF02377
Group	GO:0045196	establishment or maintenance of neuroblast polarity	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00130;PF00564;PF02828;PF07653
Group	GO:0050886	endocrine process	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00019;PF00688;PF01392;PF01433
Group	GO:0034121	regulation of toll-like receptor signaling pathway	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00041;PF00605;PF07679;PF12796
Group	GO:0016332	establishment or maintenance of polarity of embryonic epithelium	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00130;PF00564;PF02828;PF07653
Group	GO:0000186	activation of MAPKK activity	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00019;PF00688;PF00780;PF07653
Group	GO:0009624	response to nematode	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0033135	regulation of peptidyl-serine phosphorylation	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00019;PF00169;PF00452;PF00688
Group	GO:0007300	ovarian nurse cell to oocyte transport	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00307;PF00435;PF01064;PF08515
Group	GO:0040009	regulation of growth rate	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00133;PF00270;PF00271;PF00989
Group	GO:0071526	semaphorin-plexin signaling pathway	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00754;PF01403;PF01437;PF01833
Group	GO:0032479	regulation of type I interferon production	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00240;PF00271;PF00605;PF13855
Group	GO:0060972	left/right pattern formation	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF00400;PF05033;PF12796;PF13857
Group	GO:0050772	positive regulation of axonogenesis	3	4.00	3.63e-03	9.38e-03	4|324|8|3527	PF01403;PF01437;PF07679;PF13855
Group	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	4	6.29	7.00e-05	3.92e-04	4|324|4|3527	PF00019;PF00688;PF01064;PF08515
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	5.49	3.25e-04	1.33e-03	4|324|5|3527	PF00019;PF00688;PF02198;PF12796
Group	GO:0097041	phenolic phthiocerol biosynthetic process	4	5.49	3.25e-04	1.33e-03	4|324|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0097040	phthiocerol biosynthetic process	4	5.49	3.25e-04	1.33e-03	4|324|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0040021	hermaphrodite germ-line sex determination	4	5.45	7.69e-04	2.63e-03	3|324|3|3527	PF00076;PF00270;PF00271
Group	GO:0010256	endomembrane system organization	4	5.45	7.69e-04	2.63e-03	3|324|3|3527	PF01369;PF09324;PF12783
Group	GO:0090191	negative regulation of branching involved in ureteric bud morphogenesis	4	5.45	7.69e-04	2.63e-03	3|324|3|3527	PF00019;PF00086;PF00688
Group	GO:0060509	Type I pneumocyte differentiation	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00049;PF03165;PF10524
Group	GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00179;PF00515;PF12895
Group	GO:0007183	SMAD protein complex assembly	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00019;PF00688;PF03165
Group	GO:0030574	collagen catabolic process	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00045;PF00413;PF01471
Group	GO:0034122	negative regulation of toll-like receptor signaling pathway	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00041;PF07679;PF12796
Group	GO:0010216	maintenance of DNA methylation	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00271;PF01426;PF12047
Group	GO:0060510	Type II pneumocyte differentiation	4	4.56	2.86e-03	7.99e-03	3|324|4|3527	PF00049;PF03165;PF10524
